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INTRODUCTION 
Statement of the Problem 
The discovery of fructose 2,6-bisphosphate (2,6FBP), an important 
regulator of glycolysis and gluconeogenesis, was reported in 1980 (1). 
Soon thereafter, 2,6FBP was found to be a potent inhibitor of fructose 
1,6-bisphosphatase (EC 3.1.3.11) (FBPase), an enzyme important in the 
regulation of the gluconeogenesis pathway (2,3). Though numerous 
studies of the interaction of 2,5FBP and FBPase have appeared since the 
discovery of the regulator, the exact mechanism of inhibition is 
unclear. 
This dissertation describes studies performed in order to elucidate 
the mode of interaction of 2,6FBP with bovine liver FBPase. The problem 
is approached primarily by using a nuclear magnetic resonance (NMR) 
method to calculate the distance from Mn^"*" bound at the active site of 
FBPase to the phosphorus nuclei of a number of enzyme ligands known to 
bind at the active site of the enzyme. A comparison of these values 
with the analogous measurements for 2,6FBP will give an indication of 
the site of action of the regulator; that is, if the Mn^^-phosphorus 
distances obtained for 2,5FBP disagree with the measurements obtained 
for the active site ligands, then the regulator must occupy an 
allcsteric site on the enzyme. However, an agreement between the 
appropriate distances will indicate that 2,6FBP interacts with FBPase at 
the same site as the other ligands; that is, the active site. 
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The NMR method used in these studies has been the subject of 
several reviews (4-6). Basically, the technique relates the relaxing 
effect a paramagnetic ion exerts on nearby nuclei to the distance 
between the paramagnetic center and the nucleus experiencing enhanced 
relaxation. The method provides a unique means to study the confor­
mation and arrangement of individual atoms of a ligand bound to a 
macromolecule in solution. 
Additional information on the interaction of 2,6FBP with FBPase is 
obtained by using classical kinetic techniques. The reverse (nonphysio-
logical) reaction of FBPase can be monitored by using the appropriate 
coupling system (7). By observing the inhibition patterns produced by 
2,6FBP in the reverse FBPase reaction, information on the site(s) of 
action of the inhibitor is obtained, certain kinetic constants are 
calculated, and knowledge of the kinetic mechanism of the enzyme is 
gained. 
Finally we proposed to investigate the apparent synergism of the 
inhibition of FBPase activity which is observed with 2,6FBP and 5*AMP, 
an allosteric regulator of the enzyme (2,3). This problem was 
approached by using a method which monitors the binding of ligands to 
the enzyme, and the NMR method previously described. 
To reiterate, studies were undertaken to clarify the mechanism of 
2,6FBP inhibition of FBPase, with particular emphasis on determining 
whether the inhibitor acts at the active site of the enzyme, or at an 
allosteric site. The problem was approached by using an NMR method to 
map the active site of FBPase, and by using classical kinetic tech-
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niques. In addition, the mechanism of inhibition of FBPase activity 
resulting from the simultaneous presence of 5'AMP and 2,6FBP is 
investigated by using both the NMR method and binding studies-
Literature Review of Fructose 1,6-Bisphosphatase 
During early studies of glycolysis, it was noted that mammalian 
tissues could hydrolyse D-fructose 1,6-bisphosphate (FBP). Later, in 
1943, Gomori (8) described the specific phosphatase which catalyzed the 
following reaction in the presence of Mg^"*": D-fructose 1,6-bisphosphate 
+ H2O -+ D-fructose 6-phosphate + It has since become quite apparent 
that the enzyme, fructose 1,6-bisphosphatase (EC 3.1.3.11, D-fructose 
1,6-bisphosphate 1-phosphohydrolase; FBPase), plays a key catalytic role 
in the gluconeogenic pathway, as well as functioning to regulate the 
futile cycle between FBP synthesis and degradation. There have been 
several recent reviews pertaining to the mechanism and regulation of 
FBPase (9-11). 
FBPase has been isolated from a number of mammalian tissues, 
including rabbit liver (12), muscle (13), kidney (14), and intestine 
(15), as well as from bovine liver (16). The enzyme has also been 
reported in a number of bacteria, fungi, and plants; however, these 
FBPases have little in common with the mammalian enzyme (11). 
Of all the FBPases isolated, the mammalian liver enzyme has been 
the subject of the most extensive studies over the past few decades; 
unfortunately, much of the work executed before 1971 was performed by 
using proteolytically altered rabbit liver FBPase, which has an alkaline 
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pH optimum for activity. More recent purification procedures produce an 
enzyme with a neutral pH optimum for activity. 
The unproteolyzed mammalian FBPases seem to be very similar in 
molecular weight and subunit composition. For instance, FBPase from 
rabbit liver has a molecular weight of 140,000 (17) whereas the bovine 
liver enzyme has a molecular weight of 130,000 (15). Sodium dodecyl 
sulfate gel electrophoresis of mammalian FBPases from a number of 
sources has shown that the enzyme is a tetramer composed of four 
identical subunits with a molecular weight of approximately 35,000 (9). 
Using the technique of band centrifugation, Kolb has shown that the 
tetrameric form of a number of mammalian FBPases is essential for 
catalysis (18). However, FBPases from bovine (19) and rabbit (20) liver 
are reported to dissociate quite readily into the inactive subunits at 
low pH. 
A comparison of the amino acid compositions determined for a number 
of mammalian FBPases, including the bovine liver enzyme indicates a 
large degree of homology among the enzymes from different species (19). 
A comparison of the amino acid composition of FBPases from different 
rabbit tissues indicates that the rabbit liver, intestinal and kidney 
enzymes are identical, though the muscle enzyme differs slightly in 
composition (15,21). Also, FBPases from beef, pig, rat, and sheep liver 
have been shown to be immunologically different from rabbit liver 
FBPase (22), 
The bovine liver FBPase is unique with respect to amino acid 
composition, as it is reported to contain one mole of tryptophan per 
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mole of FBPase subunit, while this amino acid is absent from other 
mammalian FBPases (23), 
The amino acid sequence has been determined for several fragments 
of rabbit liver FBPase (24-26). Horecker and co-workers have reported 
the sequences of the first 78 residues of the NH^-terminus of the 
enzyme (24,25) as well as the final 88 residues of the COOH-terminus 
(26). In addition, lysine residues near the active and AMP allosteric 
sites of the rabbit liver FBPase were tagged with pyridoxal 5'-phosphate, 
and short segments about these sites were sequenced (27,28). 
Recently, the entire sequence of pig kidney FBPase has been 
determined (29). The NH2-terminal and COOH-terminal sequences are 
nearly identical to the analogous sequences in the rabbit liver enzyme, 
as were segments about the two pyridoxal 5'-phosphate-modified lysine 
residues. In addition, the sequence of a CNBr fragment of rat liver 
FBPase phosphorylated by cyclic AMP-dependent protein kinase has been 
determined (30). The peptide contains the last 43 amino acid residues 
of the COOH-terminus. Interestingly, the first 20 residues of the 
peptide are homologous with the COOH-terminus of pig kidney FBPase, 
which is not phosphorylated by cyclic AMP-dependent protein kinase, 
whereas the last 23 residues form a unique, proline rich region 
containing the phosphorylation site. 
A common feature of mammalian FBPases is the presence of a single 
highly reactive sulfhydryl group per enzyme monomer (31-35). Reaction 
of pig kidney FBPase with [ ^'*C]iodoacetamide followed by cleavage and 
sequencing of the labeled peptide indicates that only Cys-128 reacts to 
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a significant extent with the chemical modifier (36). This residue, and 
the sequence about it, was found to be highly conserved in a number of 
mammalian FBPases. 
To date, there have been no detailed X-ray crystallographic studies 
of the rePases. FBPase from avian liver crystallizes readily, but the 
crystals suffer considerable damage during X-ray analysis (37,38). 
However, FBPase from rabbit liver forms large crystals that are more 
stable under analysis. Preliminary studies of the rabbit liver FBPase 
at a resolution of 2.5 A indicate the enzyme tetramer is roughly 
spherical, with a diameter of 75 A. High resolution studies are 
reportedly in progress (39). 
The dependence of FBPase catalytic activity upon Mg^"*" was first 
reported by Gomori in 1943 (8). It was subsequently noted that Mg^"^ 
could be replaced by other divalent cations such as Mn^"*" (40), 
Zn^"*" (40), or even Co^"*" (41). It is by now quite clear that FBPases 
from all sources with the exception of brain (42), are metalloproteins 
which may bind several different metal ions. However, the number of 
metal ions bound and the sites occupied may differ depending upon 
several variables, including the ion studied, the presence of substrate 
or effectors, and the proteolysis state of the enzyme. 
Direct studies of the binding of Mn^"*" and Zn^"*" to mammalian FBPases 
have been performed. Libby et al. (43) monitored the binding of Mn^"*" to 
neutral rabbit liver FBPase by using electron paramagnetic resonance 
(EPR). In the absence of any effectors, four negatively cooperative 
binding sites for Mn^"*" per enzyme tetramer were indicated. However, in 
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the presence of the substrate analog (a+B)methyl D-fructofuranoside 
i,6-bisphosphate, a total of eight binding sites were observed, and 
the negative coopérâtivity was lost. The results show the existence of 
four structural metal ion binding sites and four catalytic sites. 
Additional studies of rabbit liver FBPase (44) showed that the products, 
F6P and P-, also induced the binding of Mn^"*" to the catalytic sites. 
Interestingly, the binding of only two equivalents of product or 
substrate analog to the enzyme tetramer was sufficient to induce all 
four of the catalytic Mn^'^-binding sites, indicating a positive 
cooperation among the sites (44). 
Similar studies have been performed to monitor the binding of Zn^"*" 
to FBPase. Both rat (45) and rabbit (46) liver enzymes appear to bind a 
total of 12 Zn^"*" ions per enzyme tetramer when studied by using a gel 
filtration technique and ^^Zn^"*". The binding of the first set of Zn^"*" 
ions is extremely tight; indeed, stringent steps must be taken to 
produce enzyme which is entirely free of Zn^"*" (47). The second set of 
Zn^"*" ions also binds tightly, with a dissociation constant of approxi­
mately 0.4 yM for both rabbit (46) and rat (45) liver FBPases. 
The third set of Zn^"*" ions shows a lower affinity for FBPase, with 
dissociation constants of 1.5 uM and 2.5 uM for the rat (45) and 
rabbit (46) liver enzymes respectively. In both cases, the binding of 
Zn^"*" to the low affinity site is competitive with Mg""*". In addition, 
the presence of substrate is necessary for the third set of Zn'"*" ions to 
bind to rabbit liver FBPase (46). These results suggest that the first 
two sites occupied by Zn^"*" are structural sites, whereas the third site 
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is the catalytic site- This postulate is supported by kinetic evidence, 
which shows that Zn^"*", which is inhibitory at very low concentrations 
(< 10 uM) activates FBPase at higher concentrations (45). 
Neutral FBPase from a number of sources is very specific with 
respect to substrate. The rabbit liver enzyme has been tested for 
activity with a number of substrate analogs, including dihydroxyacetone 
phosphate, glycerol phosphate, and D-xylulose 1,5-bisphosphate. The 
substrate analogs were all hydrolyzed by FBPase to some extent, but the 
rate of the reaction was less than 5% of the rate of reaction with 
FBP (48). 
Unlike other neutral mammalian FBPases, the bovine liver enzyme 
catalyzes significant S-glycerolphosphate hydrolysis at pH 9.0, with 
rates approaching 25% of the rate of hydrolysis of FBP at the same 
pH (49)• The 6-glycerolphosphatase activity also showed similar 
sensitivity to inhibition by the allosteric inhibitor 5'AMP. B-Glycerol-
phosphate was also a competitive inhibitor for FBP in the FBPase 
reaction at pH 9.0, indicating that the hydrolytic activity for both 
substrates arose from a common site, namely, the active site (49). 
FBP in solution is known to exist as an equilibrium mixture of four 
forms in the following percentages: 6-furanose, 90%; û-furanose, 10%; 
acyclic keto, 2%; and hydrated keto, 1.3% (50). The specificity of 
FBPase for the different forms of FBP has been investigated primarily 
through the use of substrate analogs which approximate the different 
forms of FBP in solution. 
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a-Methyl D-fructofuranoside 1,6-bisphosphate (aMeFBP) and 6-methyl 
D-fructofuranoside 1,6-bisphosphate (BMeFBP) were found to be 
competitive inhibitors of rabbit liver FBPase at concentrations less 
than 100 uM, with inhibition constants of 7.2 uM and 1.7 yM, respec­
tively (51). At higher concentrations, the B-analog, but not the a, 
inhibits in a noncompetitive fashion. These results suggest that the a 
anomer of FBP is the true substrate, and that the inhibition produced by 
high concentrations of BMeFBP may be a good model for the substrate 
inhibition of FBPase observed at high concentrations of FBP. 
The inhibition of bovine liver FBPase by substrate analogs has also 
been investigated (52). 2,5-Anhydro-D-glucitol 1,6-bisphosphate, which 
is an analog of the a anomer of FBP, gave a of 0.55 uM, whereas 
2,5-anhydro-D-mannitol 1,6-bisphosphate, an analog of the 6 anomer, gave 
a Kj of 33 nM. 
Additional information on the anomeric specificity of FBPase has 
been obtained through rapid-quench studies performed with rabbit liver 
FBPase (53). Pre-steady-state measurements indicate a rapid (5 ms) 
initial release of P^, followed by a slower (150 ms) release of P^ to 
complete the initial turnover, and finally, a steady-state rate which is 
dependent on the [aFBP]/[FBPase] ratio. Under conditions where FBP is 
limiting, the rate of the steady-state Is controlled by the B a 
solution anomerization. Though the B anomer of FBP does appear to bind 
to FBPase, these results suggest that anomerization to the a form must 
occur prior to catalysis; however, it is not clear if FBPase catalyzes 
the B a anomerization. The results strongly indicate that the a 
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anomer of FBP is the true substrate of the FBPase reaction. 
The binding of FBP to FBPase in the absence of divalent metal ions 
has been investigated by the use of a gel filtration method (43). The 
substrate binds to a total of four sites per enzyme tetramer, and the 
binding data yield nonlinear Scatchard plots that analyze in terms of 
increasing negative coopérâtivity. The dissociation constants for the 
binding of the first two substrate molecules are in the range of 10~® M, 
whereas the dissociation constants for the occupation of the third and 
fourth sites are on the order of 10"'* M. 
Binding of the products, F5P and P^, to rabbit liver FBPase has 
also been investigated (44). F6P was found to bind to the enzyme in the 
absence of divalent metal ions, though the association is promoted by 
the presence of metal ion in the order Mn^"*" > Zn^"*" > Mg^"*". As with the 
substrate, FBP, a total of four sites were occupied per enzyme tetramer. 
Similar studies of P^ binding to FBPase (44) indicate an absolute 
requirement for the presence of a divalent metal ion, with being 
more effective than Mg^"*". Again, a total of four sites were occupied by 
P^ per enzyme tetramer. 
The binding of both F6P and P^ to FBPase exhibited negative 
coopérâtivity, with the first two product molecules binding more tightly 
to the enzyme than the final two molecules (44). Additional studies 
also indicated that F6P and P^ could bind simultaneously to the enzyme, 
and that neither ligand affected the binding of the other in any 
fashion (44). 
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Finally, the binding of the nonhydrolyzable substrate analog 
(a+6)methyl D-fructofuranoside 1,6-bisphosphate to FBPase was monitored 
in the presence of Mn^"*", and found to strongly resemble the binding of 
FBP to the enzyme in the absence of metal Ion (43,44). However, the 
binding constants for the substrate analog were on the average an order 
of magnitude smaller than the analogous values for the substrate; that 
is, the substrate analog in the presence of Mn^"*" bound to the enzyme 
less tightly than did the substrate in the absence of metal ion. 
The kinetics of the bovine liver FBPase reaction have been 
investigated extensively (7,33,54-57). Various kinetic constants 
obtained from the studies are compiled in Table I. In the forward 
direction, the course of the reaction is Uni Bi if the participation of 
divalent cation is not considered; however, the amount of information 
obtainable from a one-substrate system is clearly limited, and several 
possible kinetic mechanisms for the reaction may be envisioned. Marcus 
et ai. (56) have treated the forward reaction as a Bi Bi system by 
varying FBP and and Mg^"*" in initial rate studies; however, both 
reactants displayed substrate inhibition, thus complicating more 
detailed studies. 
Though the FBPase reaction catalyzed by the rabbit liver enzyme has 
been reported to be irreversible (58), it is possible to study the 
bovine liver FBPase reaction in the nonphysiological direction (7). 
Because the back reaction is a two-substrate system, experiments could 
be carried out in greater depth and detail than had been previously 
accomplished- Studies of the reverse reaction using substrate and 
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Table I. Kinetic Parameters for the FBPase Reaction 
Parameter Explanation Source Value 
Reference 
Kg Michaelis constant for FBP 7 (0.1+0.05) x 10~® M 
7 (0.7+0.1) X 10"® M 
55 (0.25+0.08) X 10-^ M 
Kg Michaelis constant for P^ 
Kj^q Dissociation constant for P^ 
Kp Michaelis constant for F6P 
E + 2 AMP % E-AMP^, forward 
reaction 
K^ E + 2 AMP Z E-AMP^, reverse 
reaction 
7 (27.8±1.2) X 10"^ M 
7 (7.7±1.0) X 10"^ M 
7 (0.62±0.05) X 10"^ M 
55 (3.14+0.03) X 10"^° 
55 (5.65±0.31) X 10"^° M' 
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product analogs, along with studies in the forward direction using 
product inhibitors, have served to substantially narrow the possible 
kinetic mechanisms for the FBPase reaction. 
Product inhibition studies in the forward direction showed F6P to 
be a slope-linear, intercept-linear, noncompetitive inhibitor with 
respect to FBP, whereas P^ was a competitive inhibitor for the substrate 
(Table II). These results were in conformity with either an ordered Uni 
Bi sequential mechanism (Scheme 1) or a Ping-Pong Uni-Bi mechanism 
(Scheme 2), as well as two rapid equilibrium sequential mechansims (7). 
Because Casazza et al. (7) and Pontreraoli et ai. (12) have failed to 
demonstrate labeling of FBPase with [^^P]P^ or [1-^^P]FBP, the Ping-Pong 
mechanism, which would require the existence of a covalent enzyme 
phosphorus intermediate, was deemed the least likely. 
Scheme I 
14 
Table II. Inhibition Patterns for the FBPase Reaction 
Inhibitor Class Source Varied Substrate^ 
Reference FBP F6P Pi 
Pi product inhibitor 7 Comp 
F6P product inhibitor 7 NC 
Phosphite substrate analog 54 NC Comp 
2-Deoxyribose 5-P substrate analog 54 Comp NC 
2,5-Anhydromannitol-
1,6-bisphosphate 
substrate analog 54 Comp Comp 
AMP allosteric 55 NC NC NC 
^The abbreviations are: NC (noncompetitive), U (uncompetitive), 
and Comp (competitive). 
FBP F6P 
A 
E-FBP 
HgO 
E-Pi 
Scheme 2 
The classical ordered rapid-equilibrium mechanism is consistent 
with the kinetic results, if it is assumed that F6P binds at an 
allosteric inhibitory site in addition to the active site, and P^ binds 
at the active site. This mechanism was dismissed on the basis of data 
obtained in the back reaction, where both double reciprocal plots (1/v 
vs. 1/F6P and 1/v vs. 1/Pj^) intersected in the third quadrant, rather 
than on the 1/v axis as is required for an ordered rapid-equilibrium 
mechanism. However, a unique, ordered rapid-equilibrium mschanism 
(Scheme 3) of the type proposed by Frieden (59), involving the formation 
of an inactive E'F6P complex was still a possibility, and will be 
discussed. 
FBP 
1 
F6P 
ik 
(E-FBP ; E'FGP'Pj^) E-Pi E 
F6P 
E-F6P 
h.
1 
Scheme 3 
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The rapid equilibrium random mechanism (Scheme 4) also was a 
possibility in light of the results of product inhibition studies if the 
formation of an inactive FBP-F6P*E complex is assumed. The existence of 
such a complex is one explanation for the substrate inhibition observed 
in the forward reaction with FBP concentrations greater than 10 vM (56). 
However, since P^ is strictly a competitive product inhibitor, the other 
abortive complex. P: - F5P-E could net be included in the ; 3.-. 
F6P 
FBP 
FBP-E 
E-F6P 
F6P-P,- -E, 
F6P P; 
Scheme 4 
Unlike the case for The rapid-equilibrium ordered mechanism, no 
relationship exists to relate the intercepts of the double reciprocal 
plots for the reverse direction reaction to those obtained in the 
forward direction with product inhibitors. That is, the rapid 
equilibrium random mechanism could be neither verified nor eliminated by 
these experiments. The steady-state ordered mechanism also was 
consistent with the data. Because the off constant for P^ dissociation 
was much less than , an isomerization of the E-Pj^ complex was 
proposed. 
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To differentiate between the steady state and rapid-equilibrium 
mechanisms, isotope partitioning studies using [^^P]P^ were carried out 
in the reverse direction. The low level of isotope trapping strongly 
indicated a rapid equilibrium mechanism (54). These results served to 
decrease the likelihood of the iso-ordered Bi Uni mechanism, as well as 
lending additional support to the rejection of the Ping-Pong mechanism. 
To further elucidate the kinetic mechanism of FBPase, phosphite and 
2-deoxyribose-5-P were utilized as substrate analogs for P^ and F6P, 
respectively. The use of substrate analogs to distinguish between 
ordered and random bireactant mechanisms has been detailed previous­
ly (60). For the reverse reaction of FBPase, phosphite was found to be 
a competitive inhibitor for P^ and a noncompetitive inhibitor with 
respect to F6P, whereas 2-deoxyribose-5-P was a competitive inhibitor 
for F6P and a noncompetitive inhibitor for P^ (54). The rate equations 
for inhibition of the reverse reaction by phosphite were similar for the 
steady-state ordered and rapid-equilibrium random mechanism; however, 
the two mechanisms were distinguishable on the basis of inhibition by 
the F6P analog, 2-deoxyribose-5-P, with respect to P^. In the case of 
the ordered Bi Uni mechanism, the rate equation predicts 2-deoxy-
ribose-5-P will cause uncompetitive inhibition with respect to P^. 
Alternatively, for the rapid-equilibrium random mechanism, noncompeti­
tive inhibition was predicted. The results of substrate analog studies 
for the reverse reaction were more closely in accord with the latter 
mechanism because double reciprocal plots gave clearly intersecting 
lines for 2-deoxyr ibos e-5-P inhibition with respect to F6P. 
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The data therefore seemed in harmony with a rapid-equilibrium 
random Bi Uni mechanism, which included the formation of an abortive 
FGP'FBP-E complex to explain product inhibition by F5P in the forward 
direction (Scheme 4). However, a rapid equilibrium ordered mechanism of 
the type proposed by Frieden (59) involving the formation of an inactive 
E-F5P complex also was in harmony with the kinetic results (Scheme 3). 
Several methods whereby the two mechanisms may be differentiated 
have been outlined (60). The method chosen in this case was the use of 
the multisubstrate analog, 2,5-anhydromannitol-l,6-bisphosphate (59). 
For the random mechanism, the product analog would be expected to bind 
each substrate site simultaneously and therefore be a competitive 
inhibitor for both F6P and P^. Because the analog presumably would bind 
only at the active site, only the enzyme term of the rate equation would 
be affected, producing linear competitive primary plots and slope-linear 
secondary plots. 
On the other hand, with Frieden's mechanism, the analog would be 
expected to bind both the active site and the subsite for F6P. This 
would produce competitive primary plots for P^ and noncompetitive plots 
for F6P. In addition, nonlinear secondary plots can be predicted on the 
basis of multiple binding of the analog to the enzyme, resulting in 
squared terms in the rate equation. 
2,5-Anhydromannitol-l,6-bisphosphate gave linear competitive 
inhibition with respect to both F6P and Pj^. In addition, both secondary 
plots were slope linear. These results indicated the rapid-equilibrium 
Random Bi Uni mechanism (Scheme 4) to be more likely than the unique 
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ordered mechanism (Scheme 3) in the reverse reaction (59). However, if 
the forward direction is also rapid-equilibrium random, the formation of 
an abortive E-FBP-F6P complex must be proposed to explain the 
noncompetitive product inhibition observed with F6P. Although isotope 
partitioning studies indicate the reverse reaction approximates the 
rapid-equilibrium assumption, the faster forward reaction may be steady 
state; indeed, this seems to be the case for the muscle phosphofructo-
kinase reaction (61). Assuming the steady-state condition in the 
forward reaction of FBPase, it is possible to generate a rate equation 
for product inhibition consistent with an ordered mechanism with 
nonproductive binding of F6P as shown in Scheme 3 (54). 
To summarize, in light of the results of kinetic studies reviewed 
here, it is possible to select the rapid-equilibrium random Bi Uni 
mechanism as a likely possibility for rePase in the reverse direction. 
If the release of products in the forward direction is also rapid-
equilibrium, it is necessary to propose the formation of an abortive 
E*FBP*F6P complex, However, if product release is instead steady state, 
the abortive complex need not form, but F6P would be expected to form an 
inactive complex with the enzyme. 
The overall equilibrium of the FBPase reaction is 227 M, determined 
at pH = 6.99 and no free Mg^"*" (62). On the basis of rapid-quench 
studies (53), it has been calculated (9) that the equilibrium for FBP, 
F6P and Pj^ bound to the enzyme is approximately 100 M, similar to the 
value in solution. This differs from the results generally obtained 
with kinases, where the equilibrium constant in the bound state usually 
20 
is near unity (53). 
Despite numerous protein modification studies performed on FBPases 
from a variety of mammalian sources, no single amino acid has 
conclusively been shown to participate in catalysis (9). For instance, 
reaction of rabbit liver FBPase with l-cyclohexyl-3-(2-morpholinoethyl)-
carbodiimide resulted in an 85% loss of enzyme activity, and the 
inactivation could be prevented by the presence of FBP (9). The number 
and type of residue modified were not determined; however, the results 
suggest a carboxyl group may be present at the active site of the 
enzyme. 
Similarly, ethoxyformylation of rabbit liver FBPase causes a 
decrease in enzyme activity which can be prevented by the presence of 
substrate (35). In this case, it was determined that several histidine 
residues were modified, resulting in loss of catalytic activity. These 
results are particularly interesting because histidine residues are 
sometimes involved in metal ion binding sites. Possibly, FBPase 
histidine modification may disturb the binding of the catalytic metal 
ion. 
As indicated earlier, the mammalian FBPases contain one very 
reactive sulfhydryl group per enzyme monomer. The result of modifica­
tion of the bovine liver FBPase fast-reacting sulfhydryl groups has been 
studied extensively by two groups (31,33). Geller and Byrne (31) 
monitored the effect of modification of the enzyme by N-ethylmaleimide, 
l-fluoro-2,4-dinitrobenzene and 5,5'-dithiobis-(2-nitrobenzoic acid) 
under various conditions of pH and metal ion. The results were complex, 
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in as much as the sulfhydryl reagents caused either an increase or a 
decrease in enzyme activity, depending on the conditions of the 
experiment. However, in all cases, the change in enzyme activity was 
less than 50%, indicating the modification occurs at a site remote from 
the catalytic site. 
A similar study was performed by Nimmo and Tipton (33), in which 
bovine liver FBPase was reacted with p-chloromercuribenzoate and 
5,5'-dithiobis(2-nitrobenzoate). Modification of the enzyme with 
p-chloromercuribenzoate caused either an increase or a decrease in 
enzyme activity, depending on the nature of the metal ion or Mg^^) 
used in the assay; however, the change in activity was again less than 
50%. Reaction of the four thiol groups with 5,5'-dithiobis-{2-nitro-
benzoate) could be slowed by the presence of FBP. The reaction of 
FBPase with either reagent resulted in a decrease in the substrate 
inhibition observed at high FBP concentrations. 
AMP is known to be an important regulator of FBPases from a variety 
of sources. The nucleotide is a specific noncompetitive inhibitor that 
acts at an allosteric site (9). The kinetics of AMP inhibition of the 
bovine liver FBPase reaction have been studied in detail by progress-
curve analysis in the forward direction and initial rate kinetics in the 
reverse direction (55). 
Because the for FBP is quite low (Table I), initial rate studies 
of the forward reaction using the coupled spectrophotometric assay are 
technically difficult. Therefore, progress-curve analysis was used to 
measure AMP inhibition for the forward reaction (55). Fitting of the 
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data to various rate equations indicated the inhibition by AMP was best 
described as noncompetitive slope-parabolic and inhibitor-parabolic. 
In the reverse direction, AMP was again found to be a noncompetitive 
slope-parabolic, inhibitor-parabolic inhibitor with respect to both F6P 
and Pj^. Kinetic constants obtained in these studies are listed in 
Table I. For both the forward and reverse reactions, terms lower or 
higher than AMP^ were inconsequential in the rate equation, indicating 
the binding of AMP to FBPase is strongly cooperative. This observation 
agrees well with studies of the binding of AMP to the bovine liver 
FBPase (55). Scheme 5 summarizes the results obtained on the effect of 
AMP on FBPase. 
FBP 
E-(AMP) E-FBP-(AMP) 
2 AMP ^i , <-Jlii_2 AMP 
E E-FBP ^  E  +  F6P + P; 
FBP 
Scheme 5 
Nimmo and Tipton (57) originally reported bovine liver 
2 mol AMP/mol FBPase, and exhibits positive coopérâtivity. 
et ai. (64) later described the binding of AMP to FBPase as 
FBPase binds 
Arneson 
exhibiting 
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mixed coopérâtivity. In their experiments, 2 mol AMP/mol FBPase bound 
at 17 yM AMP, but it required 200 uM AMP to saturate four sites on the 
enzyme. In contrast to the rabbit liver FBPase, the substrate, FBP, 
does not affect the binding of AMP to the bovine liver FBPase (64). 
One of the most exciting recent developments in the area of 
carbohydrate metabolism has been the discovery of 2,6FBP, a regulator of 
both glycolysis and gluconeogenesis. The activating effect of 2,6FBP on 
rat liver phosphofructokinase (PFK) was first reported (as a note added 
in proof) by Van Schaftingen et al. in 1980 (1). This was closely 
followed by a similar report by Pilkis et al. (65) indicating that 
2,6FBP was an activator of rabbit muscle PFK. It was also reported that 
2,6FBP was an inhibitor of rabbit muscle and rat liver FBPases (2,3,66). 
The nature of 2,6FBP inhibition of FBPase was initially reported by 
Pilkis et al. (2) to be competitive with the substrate, whereas Van 
Schaftingen and Hers indicated that 2,6FBP changes the substrate 
saturation curve from hyperbolic to sigmoidal (66). Pilkis et al. were 
later able to confirm these results (3); however, Gottschalk et ai. (67) 
have reported competitive inhibition exclusively for pig kidney FBPase. 
All reports (2,3,66) described the inhibition produced by 2,6FBP as 
being synergistic with AMP. 
The binding of 2,6FBP to FBPases from rat liver (68) and rabbit 
liver (69) has been investigated. Rabbit liver FBPase was found to bind 
one mole of 2,6FBP per mole of enzyme monomer, with an estimated 
dissociation constant of 0.67 x 10~® M (69). A Scatchard plot of the 
binding data was linear, with no indication of cooperative interactions 
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between enzyme and inhibitor. FBP, F6P, and P^ all competed with the 
binding of the inhibitor, though AMP had no effect. High concentrations 
of Co^*, and Mn^"*" inhibited the interaction of 2,6FBP with the 
enzyme. 
Rat liver FBPase was also shown to bind one mole of 2,6FBP per mole 
of enzyme monomer (68); however, the binding exhibited marked 
coopérâtivity, with the intrinsic binding constants ranging from = 
2.0 X 10^ M~^ to Ki, = 2.0 X lo'* M~^. Binding of 2,6FBP was dependent on 
the presence of a divalent metal ion (Mn^"*" or Mg^"*"), and could be 
prevented by the substrate analogs aMeFBP and BMeFBP. AMP did not 
affect the negative coopérâtivity or the total amount of 2,5FBP which 
bound to FBPase; however, AMP did enhance the binding of the first mole 
of 2,6FBP to the enzyme, increasing the association constant by 
approximately 50% (68). 
Other mechanisms of FBPase regulation, in addition to inhibition by 
AMP and 2,6FBP, have been proposed. It is well-known that extensive 
proteolytic cleavage of mammalian FBPases will occur during purification 
if appropriate precautions are not observed. The resulting proteo-
lytically altered enzymes are characterized by an alkaline pH optimum 
for activity, and a decreased sensitivity to inhibition by AMP (11). In 
vitro proteolysis of FBPase to the so-called "alkaline" form can be 
accomplished by treatment with a variety of proteases, including 
subtilisin and lysosomal preparations which contain cathepsins (70). 
Cleavage of a number of mammalian FBPases by subtilisin has been 
characterized. Digestion of rabbit liver FBPase by subtilisin liberates 
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a 5500 molecular weight peptide from the amino terminus of the 
enzyme (71). Recently, the site of cleavage of pig kidney FBPase by 
subtilisin was investigated. In this case, the peptide contained 60 
amino acids, and the entire sequence was determined (72). Though 
proteolysis resulted in decreased sensitivity to AMP inhibition, no AMP 
interaction site could be detected on the peptide. 
A unique lysosomal protease which acts on both PFK and FBPase was 
purified from rabbit liver by Pontremoli et al. (73). The protease, 
designated cathepsin M, cleaves a small fragment from the carboxy-
terminus of FBPase, leading to a decrease in enzyme activity. 
Interestingly, the inactivation can be reversed by the addition of 
cystamine, which probably forms a mixed disulfide derivative with the 
enzyme sulfhydryl groups (74). 
The possibility that FBPase activity may be regulated by the 
phosphorylation state of the enzyme has alos been investigated. Rat 
liver FBPase is a substrate for the catalytic subunit of cAMP-dependent 
protein kinase, which incorporates one mole of phosphorus per mole of 
FBPase monomer (75,76). In vivo phosphorylation of rat liver FBPase has 
also been shown to occur (75,76); indeed, purified FBPase exhibits 
multiple forms upon isoelectric focusing, which have been attributed to 
differing states of phosphorylation (77). The effect of phosphorylation 
on the activity of FBPase is unclear. Riou et al. reported a slight 
increase in phosphorylated FBPase activity (75), whereas Chatterjee 
et ai. stated that enzyme activity is independent of the phosphorylation 
state (76). McGrane et al. have suggested that the discrepancy may be a 
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result of different degrees of phosphorylation of the enzyme, which 
subsequently causes differences in the regulation of FBPase 
activity (77). 
Recently, it has been suggested that the oxidation state of FBPase 
thiol groups may play a role in the regulation of enzyme activity (78). 
Two forms of FBPase were isolated from rat liver in the presence (A) and 
absence (B) of dithiothreitol. Forms A and B had identical molecular 
weights and the same for FBP; however, they differed in their 
reactions with thiol reagents, and showed dissimilar sensitivity to AMP 
inhibition. Form A, the more reduced form of FBPase, showed 22.4 thiol 
groups per enzyme tetramer, 2.5 of these being the "fast-reacting" type. 
Form B, the more oxidized form of the enzyme, contained 19.2 thiol 
groups, 0.5 fast reacting. The for AMP inhibition was 140 uM for 
form A, and 370 yM for form B. However, form B regained sensitivity to 
AMP inhibition if 1 mM dithiothreitol was included in the assay. The 
effect of oxidation state on 2,6FBP inhibition was not investigated, but 
may prove interesting. In any case, the results suggest that the redox 
state of the enzyme may be important in controlling FBPase activity. 
The hormonal regulation of gluconeogenesis has been intensively 
investigated, and several recent review articles pertaining to this 
topic have been published (79-81). Glucagon is known to increase the 
rate of gluconeogenesis in the liver while inhibiting glycolysis. 
Specifically, glucagon has been reported to raise the flux through 
FBPase, and to increase enzyme activity (82,83). The activities of 
PFK (82) and pyruvate kinase (84) are also affected by glucagon. 
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The effect of glucagon on pyruvate kinase activity clearly arises 
from phosphorylation of the enzyme by cAMP-dependent protein kinase, 
which results in a decreased affinity for the substrate, phosphoenol-
pyruvate. However, until recently, the mechanism of the glucagon effect 
on PFK and FBPase was unclear, as phosphorylation of both these enzymes 
only negligibly changes their activity. 
It now appears the glucagon effect on both PFK and FBPase is 
mediated by 2,6FBP (85,86). Soon after the discovery of 2,6FBP, enzyme 
activities responsible for synthesis of the regulator from F6P and 
ATP (87-89), and degradation to F6P and P^ (90,91) were reported. 
Interestingly, a single protein is responsible for both activities 
(90,91). The enzyme (6-phosphofructo-2-kinase/fructose 2,6-bisphos-
phatase), when phosphorylated by cAMP-dependent protein kinase in 
response to glucagon, catalyzes the degradation of 2,6FBP (90,91). 
However, the unphosphorylated enzyme catalyzes the synthesis of 2,6FBP. 
Therefore, glucagon potentiates FBPase activity in vivo by promoting the 
cAMP-dependent phosphorylation of 6-phosphofructose-2-kinase/fructose 
2,6-bisphosphatase, thereby causing 2,6FBP to be degraded, and relieving 
the inhibition of FBPase (85,86). 
In conclusion, FBPase plays a key role in the control of gluconeo-
genesis, and as such is highly regulated. The enzyme is regulated by 
the inhibitor 2,6FBP, which in turn is under the control of the hormone 
glucagon. AMP also is an important regulator of FBPase, though the 
mechanism causing AMP levels to vary is unclear. FBPase may also be 
regulated by phosphorylation, oxidation/reduction, or the presence of 
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metal ions or product; however, the effects produced are probably minor 
compared to the inhibition produced by 2,6FBP and AMP. Interestingly, 
no activators of FBPase have yet been reported. 
Review of Paramagnetic Nuclear Relaxation Theory and Methods 
A myriad of methods are available for studying the interaction of 
small" compounds with macromolecules; however, NMR and X-ray crystal­
lography are unique in permitting the "observation" of individual atoms 
within a macromolecular complex. A number of review articles (4-5, 
92-95) and texts (97,98) describing the theory and various biochemical 
applications of NMR have been published. 
When nuclei with spin 1=1/2 (i.e., protons or phosphorus nuclei) 
are placed in a stable magnetic field, they will disperse between two 
energy levels corresponding to orientations of the spins parallel and 
antiparallel to the magnetic field. This may be visualized by picturing 
the dipoles aligned with the magnetic field as lying on the positive z 
axis (+z), and those opposed to the magnetic field as lying on the 
negative z axis (-z). The equilibrium population of the two'energy 
levels is determined by the energy difference between them, and more 
dipoles are aligned in the +z direction, so that the vector sum of the 
magnetic moments of the nuclear spins (the total magnetization) is 
aligned in the direction of the applied magnetic field. 
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Just as in other types of spectroscopy, NMR arises from transitions 
in energy levels. In this case, the equilibrium of the system is 
perturbed by the absorption of energy from an applied electromagnetic 
field. The approach of the perturbed system back to equilibrium occurs 
exponentially with time, and is described by the time constants 
and Tg. 
More exactly, the application of a radio-frequency pulse in the 
y-axis direction "flips" the total magnetization into the x-y plane. 
Upon cessation of the pulse, the dipoles begin to precess about the z 
axis direction. The precessing dipoles dephase in the x-y plane because 
the precession frequencies of the individual dipoles differ; hence, the 
total magnetization decreases exponentially with a time constant, T2-
Of course, tipping M into the x-y plane decreases the magnitude of 
the macroscopic magnetization vector in the +z direction. At the same 
time that the dipoles precessing in the x-y plane are losing phase 
coherence, they are also realigning with the applied magnetic field. 
Therefore, the magnetization in the +z direction exponentially 
approaches the equilibrium value in a manner described by a time 
constant, T^. Because realignment of the dipoles with the z-axis 
decreases the magnetization in the x-y plane, T^ is always greater than 
T2, and any factors which affect Tx will also affect Tg. 
Ti relaxation occurs because of the ability of the nuclear spin 
system to transfer excess energy to the surroundings; hence, Ti is also 
known as the spin lattice relaxation time. In liquids, the rapid random 
motion of molecules results in fluctuating magnetic or electric fields 
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of a range of frequencies. That component of the frequency spectrum 
that is equal to the resonance frequency, called the Larmor frequency, 
"o, is necessary for effective energy exchange leading to relaxation. 
The magnitude of the component of the frequency spectrum at the 
resonance frequency depends upon several factors, including molecular 
motion, the magnitude of magnetic moments in the surrounding nuclei, and 
intermolecular and intramolecular interactions. The dependency upon 
molecular motion is expressed by a correlation function that defines the 
position of a molecule at time t relative to its position at an 
arbitrary initial time. The time required for the change of position is 
the correlation time, 
As mentioned, any factor which promotes T^ relaxation will also 
lead to T2 relaxation. However, additional contributions to T2 
relaxation will arise if the tumbling of the molecule in solution is 
insufficient to average out the magnetic fields generated by neighboring 
spins. In this case, energy can be exchanged between nuclei, giving 
rise to T2, or spin-spin relaxation. 
Obviously, relaxation by either the T^ or T2 process will only 
occur as a result of some specific interaction between the nucleus and 
its environment which results in an energy exchange. Several types of 
interactions have been identified, and include nuclear magnetic 
dipole-dipole interaction, chemical shift anisotropy, spin-rotation 
interaction, nuclear electric quadrupole interaction, scalar coupling 
effects, and the effect of paramagnetic species. The effect of 
paramagnetic species will be discussed in some detail below. Other 
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relaxation mechanisms are less pertinent to this discussion, and are 
described in detail elsewhere (97-99). 
Paramagnetic ions contain an unpaired electron, and therefore have 
a large magnetic moment in comparison to dipolar nuclei. This results 
in a strong, fluctuating magnetic field about the paramagnetic nucleus, 
which may in turn provide an efficient relaxation mechanism for 
neighboring nuclei. 
A knowledge of the conformations and arrangements of ligands bound 
to the active site of an enzyme in proximity to a paramagnetic ion can 
be gained by observing the paramagnetic effect on the individual nuclei 
of the ligands. The relaxing effect of an enzyme-bound paramagnetic ion 
on nearby nuclei depends primarily on the following parameters: the 
lifetime of the complex the relative stoichiometry of the 
substrate and paramagnetic ion in the complex (q), the correlation time 
for the electron-nuclear dipole interaction (t^), and the distance (r) 
between the paramagnetic ion and the nucleus in the complex. Thus, if 
certain restrictions of the exchange rate are met, and and q are 
known, the value of r can be obtained. 
The observed paramagnetic contribution to the relaxation rate of a 
nucleus of a ligand in exchange with a paramagnet-enzyme complex 
(1/Tip), is described by the Swift-Connick equation (100): 
1/Tip = fq/(tm + Tim) 
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where f is the fraction of ligand bound to the paramagnet-enzyme complex, 
is the lifetime of the bound complex (and the reciprocal of the dis­
sociation constant, J^^issK and Ti^ is the relaxation rate of the ligand 
nuclei in the bound state. An analogous equation describes the observed 
paramagnetic effect on Tg. Obviously, for 1/Txp to be a good estimate of 
fq/Tijn, the lifetime of the ligand-enzyme-paramagnet complex should be 
short; that is, the ligand must be in fast exchange with the enzyme. 
A number of methods are available to determine if a ligand-enzyme 
system is in fast, slow, or intermediate exchange. The simplest method 
involves determining the ratio of Tip/T2p. If exchange is slow, then 1%, 
will dominate l/T^p, and hence l/Tzp? therefore, Tip will be approxi­
mately equal to T^p, and the ratio will equal one. On the other hand, 
if the chemical exchange rate is fast, the two relaxation rates will not 
be equal, and will be greater than one. 
Alternatively, the exchange mechanism may be determined by 
monitoring the effect of temperature on either Tj or T2. Because T2 is 
related to the linewidth of the resonance arising from a nucleus by the 
relationship I/T2 = ir (linewidth at half-height in hertz), it is usually 
simplest to monitor T2 with changing temperature. If the system is in 
slow exchange, T211, will be less than and the linewidths will 
increase with increasing temperature, which decreases the lifetime of 
the bound state. 
However, in the fast exchange limit, tjj, is less than Tzm- Because 
1/T2m is a function of the enzyme-ligand correlation time, the 
observed linewidth will narrow with increasing temperature, due to a 
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decrease in Finally, if intermediate exchange conditions prevail, 
changes in tj,, will counteract changes in T2m, and little change in the 
linewidths will be observed. 
If fast exchange conditions prevail for a particular system, the 
distance r in angstroms between the enzyme-bound paramagnet and the 
nuclei of nearby ligands can be obtained by using the modified 
Solomon-Bloembergen equation (101): 
3t 
r(Â) = C[f-Tip( —-)] 
1 + 
where is the Larmor precession frequency, and C is a collection of 
constants for a specific paramagnet-nucleus interaction. 
The use of the Solomon-Bloembergen equation to determine the 
distance between an enzyme-bound paramagnetic center and the nuclei of 
various ligands requires that a number of criteria be fulfilled. For 
instance, it must be shown that T^p is not exchange limited, as 
previously mentioned. It also is important that outer sphere contribu­
tions to the relaxation rate be small. For the interaction of para­
magnetic ions and ligands free in solution, outer sphere effects may be 
significant. However, in the enzyme-bound complex, it is unlikely any 
ligand except that specifically bound to the enzyme in proximity to the 
paramagnetic center will experience enhanced relaxation. Also, any 
nonspecific interactions between the bound paramagnetic ion and ligand 
in solution are likely to take place over a large distance, and will 
contribute little to Tip relative to the ligand specifically bound in 
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close proximity to the paramagnetic center. 
In addition, the hyperfine contact contributions to 1/Tip should be 
small. This criterion is met if the paramagnetic ion has a visible EPR 
spectrum at room temperature, or if the ligand is not directly 
coordinated to the paramagnet. 
As mentioned previously, the use of the Solomon-Bloembergen 
equation for determing paramagnet-1igand distances requires a knowledge 
of tj,, which is given by: 
where is the rotational correlation time, tg is the electron-spin 
relaxation time, and is the residence time of the nuclear species in 
the bound state. Obviously, is dominated by whichever time is 
shortest: Xg or TJJ,. 
Several methods are available for the evaluation of The most 
accurate method measures of the nucleus for which the distance is 
desired by monitoring the frequency dependence of T^p of the ligand 
nuclei. Commonly, this measurement is made on separate instruments at 
different magnetic fields; however, if two magnetically active isotopes 
of the same nucleus are available (e.g., the frequency 
dependence study can be done at one magnetic field, because is 
different for each isotope (6). In any case, the method assumes that 
the ligand is in the fast exchange limit, and that the correlation time 
is frequency independent. The latter assumption is usually valid for 
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biological systems where is in the range of seconds. 
The correlation time may also be obtained from the ratio Tip/Tzp 
for a particular nucleus. This method assumes the fast exchange limit, 
and that hyperfine and paramagnetic shift contributions to Tgp are 
negligible. Unfortunately, atoms heavier than protons have been 
reported to experience significant contact and shift contributions to 
Tzp, resulting in an overestimation of by as much as an order of 
magnitude when compared to obtained by using other methods (102,103). 
Therefore, the T^p/T^p ratio method is most safely applied to those 
ligands which contain easily monitored protons. 
A third method for obtaining involves monitoring the relaxation 
rates of the solvent water in the system, assuming for the water 
hydrogens in the first hydration sphere of the paramagnetic ion is equal 
to Tj, for the other nuclei under observation. The correlation time may 
then by obtained either from the ratio Tip/T2p as previously described, 
or from the relaxation enhancement of the water protons when the 
paramagnetic enzyme-1igand complex is present, provided q is known (97). 
In either case, the method assumes that hyperfine contributions to l/Tj^i 
are small, and that the metal-water distance in the paramagnetic complex 
is the same as the value in pure aqueous solution. 
The correlation time may also be estimated by measuring the 
linewidth of a single transition in the EPR spectrum of a solution of 
the paramagnetic complex. This method actually estimates and 
therefore provides a lower limit for t^.. The method is most useful in 
confirming other determinations, and may help determine the relative 
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contribution of tg to tj,. 
In addition, the Stokes-Einstein equation may be used to estimate 
Tj., assuming the molecular weight of the complex is known. Because it 
is unlikely that any mechanism determining -r^ will be longer than 
this method provides an upper limit for 
The potential for obtaining structural information in biochemical 
systems from the relaxing effects of paramagnetic ions was first 
recognized by Eisinger, Shulman, and Szymanski in 1962 (104). In 
studying the binding of paramagnetic ions to DNA, this group noted that 
solvent water relaxation rates of the samples containing paramagnet-DNA 
complexes were increased significantly over the rates obtained for 
samples of the paramagnetic ion alone. Soon after this observation was 
made, a similar phenomenon was reported for Mn-enzyme and Mn-enzyme-
ligand complexes by Cohn and Leigh (105). 
Since 1962, the measurement of nuclear magnetic relaxation rates in 
the presence of paramagnetic probes has been used extensively to study 
the arrangement and conformation of enzyme-bound substrates. Early 
studies were performed primarily on water or other ligands with 
identifiable proton resonances. However, the development of high-field 
spectrometers with Fourier transformation capacity has increased 
sensitivity and allowed distance measurements to be performed on a 
number of other nuclei, including ®Li, and 
In addition, a number of paramagnetic probes have been utilized in 
relaxation studies. The most commonly used probe is Mn(II), which is an 
activating divalent cation for a number of enzymes. In other cases. 
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zinc may be substituted with Co(II), which is paramagnetic. Even 
proteins such as immunoglobulins which do not require a metal ion for 
protein function may have specific binding sites for paramagnetic 
lanthanide ions such as Gd(II). Finally, if a protein does not 
specifically bind a paramagnetic species, it is sometimes possible to 
introduce a probe by using one of the following methods. 
First, it may be possible to directly introduce a stable free 
radical probe in the form of a spin label. The most common spin labels 
contain a nitroxide moiety which has an unpaired electron. The 
nitroxide group is often covalently attached to some functional group 
which itself will react with amino acid residues of a protein; for 
instance, many spin labels contain an iodoacetamide group and therefore 
react primarily with sulfhydryl residues. 
It is also possible to introduce a paramagnetic probe by using 
substrate or inhibitor analogs containing an unpaired electron. For 
instance, ATP and AMP analogs which contain a nitroxide group attached 
at N-6 of the adenine ring have been used to study nucleotide-binding 
enzymes (97). Similarly, substitution-inert Cr(III) derivatives of 
nucleotides have been developed to aid in the study of the metal-
nucleotide environment of enzymes (5,106). 
By monitoring the paramagnetic effect on the longitudinal relaxation 
rates of ligand nuclei, distances up to 24 A from a paramagnetic center 
have been calculated (107). A comparison of distances obtained by the 
NMR method with the corresponding measurements obtained by using X-ray 
crystallography generally yields a good correlation between the two 
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methods. This is especially true for smaller paramagnet-ligand 
complexes. However, in certain cases involving macromolecular 
complexes, the X-ray crystallographic and NMR results may disagree. For 
instance, the geometry of the alcohol dehydrogenase active site has been 
intensively investigated by NMR, X-ray crystallography, and fluorescence 
spectroscopy (4,93,108). The results obtained from the different 
methods for a number of ligands bound to Co(II) or Zn(II) alcohol 
dehydrogenase are qualitatively similar inasmuch as the substrates 
appear to have the same basic conformation when bound at the active site 
of the enzyme, regardless of the method used to determine the confor­
mation. However, the results of X-ray crystallographic studies suggest 
the substrate is directly coordinated with the active site metal ion, 
whereas NMR studies suggest a second-sphere mode of interaction between 
metal ion and substrates. Because the crystalline alcohol dehydrogenase 
is much less active than the enzyme in solution, the discrepancy 
probably is a result of structural differences between the two states. 
In this case, then, the NMR method is thought to more accurately 
describe the geometry of enzyme-bound ligands in the physiological state 
than does X-ray diffraction. 
Measurement of nuclear magnetic relaxation rates of substrate atoms 
in the presence of enzyme-bound paramagnetic probes has been used to 
determine ligand conformations for a number of enzyme systems. An 
excellent comprehensive review by Burton et al. (93) describes the 
application of the method to twelve different enzyme systems, as well as 
three nonenzyme systems, and several polynucleotide systems. Of course, 
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studies of the active site and allosteric site topography of FBPase by 
the nuclear magnetic relaxation method are particularly relevant to this 
literature review, and will be discussed in some detail below. 
In 1973, Benkovic and his coworkers (109) investigated both the 
binary fructose-l-phosphate (FlP)-Mn(II) complex and the ternary 
FlP-Mn(II)-FBPase complex by using ^^P and NMR. This group found 
that FIP is a poor substrate for rabbit liver FBPase, being hydrolyzed 
at a rate 0.3% that of FBP; in addition, the for the reaction was 
0.62mm, several orders of magnitude higher than the for FBP. 
Therefore, it was reasoned that FIP was a better candidate for NMR 
measurements than FBP, because FIP was less likely to be exchange 
limited, and less hydrolysis would occur during the course of the 
experiment when FBPase was present. 
In initial experiments, T^ and of the and ^^P resonances of 
FIP in solution were monitored in the presence and absence of MnClg. 
Both relaxation rates were shortened by the presence of the paramagnetic 
ion, and the ratio Tip/Tgp was greater than 1, indicating Ti is not 
limited by chemical exchange. The Stokes-Einstein equation was used to 
determine that = 5.0 x 10~^° seconds for the Mn-FlP complex. By 
using the Solomon-Bloembergen equation, it was determined that Mn was 
between 2.1-2.8 A away from C-1, C-2, C-3, C-4, and C-5 of FIP, whereas 
the distance between Mn and C-6 could not be determined because of 
C-6 was not affected by the presence of Mn. Similarly, the distance 
between Mn and the phosphate group of FIP was determined to be 2.4 Â at 
pH = 5.8 and 3.2 A at pH = 7.5. 
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In addition, the distance between Mn and the phosphate group of FIP 
was measured in the presence of FBPase. Again, l/fT^p was less than 
l/fT2p, indicating the system is in fast exchange. The correlation time 
was estimated by using both Stokes' law and the ratio of Tip/T2p. The 
values obtained were 2-5 x 10~® seconds, representing an upper limit for 
Tj,. The Mn to phosphorus distance obtained for the FlP-Mn-FBPase 
complex was 2.5 Â at pH = 5.8, and 3.2 Â at pH = 1.5. 
The results presented by Benkovic et al. (109) suggest that Mn is 
directly coordinated to the phosphate group of FIP in both the binary 
and ternary complexes, because inner coordination complexes typically 
give distances in the range of 2.8-3.2 Â (93). However, the distances 
obtained in the presence of FBPase may be spuriously short for two 
reasons. 
Firstly, it is possible that binary complexes of the type FlP-Mn 
may be contributing to the relaxation rates attributed to the ternary 
complex, FlP-Mn-FBPase. Because the for FIP is relatively high, it 
is quite possible that the association constant is quite low, resulting 
in a significant amount of unbound FIP which may form a binary complex 
with Mn. Secondly, the value for tj, used in the distance measurement 
calculations was an upper limit because, as previously mentioned, the 
Stokes-Einstein equation gives only and because the Tip/Tzp ratio 
method may include hyperfine contributions to Tg when applied to 
phosphorus nuclei (102,103). 
The NMR studies of Benkovic et a l .  (109) on the FIP binding 
site of rabbit liver FBPase were extended by Cunningham et ai., who 
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determined the Mn-^^P distances for enzyme-bound F6P, P^ and AMP, as 
well as the Mn-^H distances for H-8, H-2, and H-1' of AMP (110). In 
these studies, was estimated by three independent methods. The ratio 
of Tip/T2p (obtained by using results for H-8 of AMP) was used to 
estimate as was the EPR spectrum of enzyme-bound Mn. In addition. 
Tip was determined for P^^ and AMP by using ^^P NMR at two frequencies, 
and the results were used to calculate An average of obtained by 
the three different methods was 1.8 x 10~® seconds, at least an order of 
magnitude lower than the value presented by Benkovic et al. (109). 
Because the ratio of Tip/T2p obtained by using ^^P NMR was between 
100 and 200 for the three ligands used in the study, the criterion that 
the system be in fast exchange was satisfied; hence, the Solomon-
Bloembergen equation could be applied to obtain Mn-nuclei distances. 
The Mn-^ip distances obtained for F6P and P^ were both 5.3 Â, whereas 
the Mn-^^P distance for AMP was 5.2 A. The Mn-^H distances for H-8, 
H-2, and H-1' of AMP were 4.1 Â, 6.8 A, and 7.3 A, respectively. It was 
also noted that the Mn-^^P distances for F6P and P^ were lengthened 
slightly when the ligands were simultaneously bound to the enzyme. 
In addition, Cunningham et ai. (110) introduced an additional 
paramagnetic probe by reacting the FBPase with a nitroxide spin label 
which modified four enzyme sulfhydryl groups per tetramer. However, the 
spin label had no effect on the relaxation rates of F5P and P^ phosphate 
groups. By using thee EPR method, for the spin-labeled enzyme was 
obtained, making it possible to calculate that the nitroxide group was 
greater that 9.6 A removed from P^ and the phosphate of F6P. Finally, 
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by monitoring the effect of Mn on the EPR spectrum of spin-labeled 
FBPase, it was possible to estimate that the distance between enzyme-
bound Mn and the spin label is about 16 Â (97,110). 
In conclusion, important information on the mechanisms of enzyme 
catalyzed reactions may be obtained by measuring nuclear magnetic 
relaxation rates in the presence of paramagnetic probes. However, the 
proper use of the technique requires that a number of criteria be met, 
and that the appropriate correlation times be carefully determined. The 
method has previously been applied to the study of the mechanism of 
rabbit liver FBPase; studies presented in this dissertation also use 
paramagnetic relaxation techniques to further elucidate the mechanism of 
bovine liver FBPase. 
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PART I. THE EFFECT OF FRUCTOSE 2,6-BISPHOSPHATE ON 
THE REVERSE REACTION KINETICS OF BOVINE LIVER 
FRUCTOSE 1,6-BISPHOSPHATASE 
44 
INTRODUCTION 
FBPase (EC 3.1.3.11) catalyzes the hydrolysis of FBP to form F6P 
and in the presence of a required divalent cation. The enzyme is a 
crucial control site in gluconeogenesis and, as such, is highly 
regulated by several effectors, including AMP and 2,6FBP. The FBPase 
reaction has been studied extensively in the forward (physiological) 
direction (9), but these investigations have been ineffective in 
elucidating the manner of product release because technical problems for 
some time precluded the use of product inhibition studies, and in 
addition, the amount of information obtainable in a Uni system is 
limited inherently. The exergonic hydrolysis of FBP until recently was 
considered irreversible (58). However, it was demonstrated that the 
reaction of FBPase is kinetically reversible (7), and studies of the 
reverse reaction have substantially narrowed the possible kinetic 
mechanisms (54). 
Using results of product inhibition studies in the forward reaction 
and initial-velocity studies of the reverse reaction of FBPase, it was 
possible initially to eliminate from consideration the conventional 
rapid-equilibrium Ordered Uni Bi mechanism. Further studies on the 
reverse reaction utilizing substrate analogs indicated that the 
steady-state Ordered and Ping Pong Uni Bi mechanisms were not consistent 
with the data. In addition, isotope partitioning experiments indicated 
that the reverse reaction approximates the rapid-equilibrium assumption. 
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The results obtained thus far were in accord with a rapid-equilib­
rium Random Bi Uni mechanism, as well as a unique rapid-equilibrium 
Ordered Bi Uni mechanism of the type proposed by Frieden (59), with F6P 
binding to a site other than the active site (54). Several methods have 
been suggested whereby these two mechanisms may be differentiated, 
including the use of multisubstrate analogs (60). 
Recent reports have indicated that 2,6FBP is a potent competitive 
inhibitor for FBP in the forward reaction (2,65). Pilkis et al. (3) 
have presented additional evidence suggesting that 2,6FBP may be an 
allosteric effector of the enzyme and also may act at the active site. 
These results and the obvious similarity of 2,6FBP to FBP suggested the 
use of the former compound as a multisubstrate analog for studying the 
reverse reaction. This section presents the results of these studies 
and the conclusion that the most probable mechanism for the reverse 
reaction is rapid-equilibrium Random Bi Uni. In addition, our data 
serve to shed additional light on the interaction of 2,6FBP with FBPase. 
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MATERIALS AND METHODS 
FBP, trisodium salt, F6P, disodium salt, NADP, sodium salt, 
L-histidine, Tris(hydroxymethyl)aininomethane (Tris), phenylmethyl-
sulfonylfluoride, phosphoglucoisomerase, aldolase, and rabbit muscle 
FBPase were purchased from Sigma. Affi-gel Blue, 100-200 mesh, was 
purchased from Bio-Rad. Glucose-6-P dehydrogenase and glycerolphosphate 
dehydrogenase were purchased from Boehringer Mannheim. All other 
reagents were of the highest quality commercially available. Distilled 
deionized water was used in the preparation of all reagents. 
Enzyme Preparation 
FBPase was purified from bovine liver, as described (54), with the 
following modification. After phosphocellulose chromatography, the 
enzyme was dialyzed against 10 mM Tris-HCl, pH 8.5, and applied to an 
Affi-gel Blue column (1.5 cm x 30 cm). After washing with five column 
volumes of buffer, the enzyme was eluted with 25 yM AMP in 10 mM 
Tris-HCl, pH 8.5 (111). Enzyme prepared in this fashion had a specific 
activity of 22.0 I.U./mg, and a pH 6.5:9.0 activity ratio of at least 
2 . 0 .  
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Enzyme Assays 
The coupled spectrophotometric assay used to measure the reverse 
FBPase reaction has been described previously (7). The assay couples 
the production of FBP to the aldolase reaction to produce dihydroxy-
acetonephosphate and D-glyceraldehyde-3-phosphate. D-Glyceraldehyde-
3-phosphate is converted to dihydroxyacetonephosphate by triosephosphate 
isomerase, and dihydroxyacetonephosphate is reduced to glycerol-
3-phosphate in the presence of NADH and glycerolphosphate dehydrogenase. 
All assays contained 25 mM Tris/25 mM histidine (pH 5.5), 8 mM MgSO^, 
0.125 mM NADH, 4.5 units of aldolase, 29 units of triosephosphate 
isomerase, and 2.5 units of glycerolphosphate dehydrogenase. All assay 
components except were incubated at 28°C for 5 minutes, before 
initiation of the assay by P^. Absorbance changes at 340 nm were 
monitored on a Gary 118 spectrophotometer, using the 0.02 optical 
density full scale setting. 2,6FBP was added in a small volume of 
0.01 N NaOH; uninhibited assays contained the same volume of 0.01 N NaOH 
alone. The final volume of the assays was 1.0 ml. 
The forward FBPase reaction was monitored spectrophotometrically by 
using a coupled assay based on that originally developed by Pontremoli 
(7,112). The assay mixture contains 25 mM Tris/25 mM histidine, pH 5.5, 
5 mM MgSO^, 0.2 mM NADP, 5.3 units of phosphoglucoisomerase, and 5 pM 
FBP. The total assay volume was 1.0 ml, and the temperature was 
maintained at 28°C. 
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The kinetic data from the reverse reaction studies were analyzed by 
using a computer program written in the OMNITAB II language (113). 
Preparation of 2,6FBP 
Several methods for the preparation of 2,6FBP have been described 
(65,114,115). In all cases, FBP is reacted with dicyclohexylcarbodiimide 
to form D-fructose-1,2-cyclic 5-bisphosphate (116), which is then 
hydrolyzed with base to form a mixture of FBP and 2,6FBP. Van 
Schaftingen and Hers (115) separated the mixture by first converting FBP 
to F6P by using FBPase, and then separating the resulting P^, F6P and 
2,5FBP on a column of Dowex AGI. Pilkis et ai. (65) hydrolyzed FBP to 
F6P by using base hydrolysis at high temperature, and separated the 
resulting mixture on a column of DEAE-Sephadex. Uyeda et al. (114) also 
hydrolyzed FBP by using base hydrolysis, but separated the resulting 
mixture by using paper chromatography. 
All three methods were used to prepare 2,6FBP for use in these 
studies. The method described by Van Schaftingen and Hers (115) was 
found to be the most successful for the following reasons: first, FBPase 
was used to degrade FBP in order to facilitate its separation from 
2,6FBP. The other methods (65,114) involve heating the sample to 90°C 
for 30 minutes in the presence of 0.25 N NaOH, which in my hands 
generated rearrangement products that appeared as contaminants in the 
final 2,6FBP preparation. Second, Van Schaftingen and Hers (115) used 
Dowex AGI column chromatography to separate the final products of the 
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synthesis. I found this column to have a higher capacity and superior 
flow characteristics when contrasted with the other chromatography 
techniques (65,114). Therefore, 2,6FBP was prepared essentially as 
described (115) with minor modification. 
FBP (2.5 g, trisodium salt) was dissolved in 10.0 ml of water and 
passed over a 0.9 cm x 27 cm Dowex 5W (X-8) column in the H+ form. The 
carbohydrate-containing fractions were detected by charring, and the 
pooled fractions were adjusted to pH 7.0 by the addition of approximately 
2 ml of pyridine. A mixture containing 7 ml of the FBP solution, 0.5 ml 
of triethylamine and 20 ml pyridine was assembled, and the cyclization 
reaction was initiated by the addition of 2.4 g dicyclohexylcarbodiimide 
in 10 ml of pyridine. The reaction was allowed to proceed for 24 hrs at 
25°C and then stopped by the addition of 40 ml of water. The mixture 
was passed through a sintered glass filter, and then extracted with five 
200 ml portions of ether. 
The D-fructose-1,2-cyclic 6-bisphosphate contained in the aqueous 
phase was hydrolyzed to FBP and 2,6FBP by the addition of 0.2 volumes of 
2.5 N NaOH (approximately 6.0 ml) followed by incubation at 37°C for 30 
minutes. Solid glycine was added to a concentration of 20 mM, and the 
solution placed on ice, after which 2 N HCl was used to adjust the pH 
to 9.4. 
To facilitate the removal of FBP from 2,5FBP in the mixture, FBP 
was hydrolyzed to F6P and P^ by using FBPase. The solution was brought 
to 90 ml by the addition of water, and MnCl2 was added to a final 
concentration of 0.5 mM. Rabbit muscle FBPase was added to give 0.4 
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units of enzyme per ml of solution, and the mixture was incubated for 
3 hr at 30°C. 
Following the degradation of FBP, the resulting mixture of F6P, P^ 
and 2,6FBP was separated by column chromatography. The mixture was 
diluted with water to a final volume of 450 ml, and applied to a 0.9 cm 
X 30 cm column of Dowex AGI (X-2) in the chloride form. The column was 
developed with a linear gradient of NaCl, 100 mM-400 mM, in a total 
volume of 250 ml. Fractions containing 3.0 ml were collected and 
assayed for F6P by using the method described for assaying the forward 
FBPase reaction, omitting FBPase. Fractions were also assayed for 
2,6FBP, by monitoring the inhibitory effect of aliquots of the fractions 
on the forward FBPase reaction. 
Column fractions containing 2,5FBP were pooled, and the concentra­
tion of 2,6FBP was determined by the assay of acid-revealed F6P (65,114, 
115). The final yields of the preparations were typically between 
3.2-5.0%, and the preparations contained about 5% contaminating FBP. 
The structure and purity of the final product was confirmed by using ^^p 
NMR spectroscopy, with and without proton decoupling (117). 
RESULTS AND DISCUSSION 
The results of 2,6FBP inhibition of the FBPase reaction are shown 
in Figures 1 and 2. In both cases, one substrate was held at a constant 
concentration near its value while the other substrate was varied in 
the presence of 0-6 uM inhibitor. Figure 1 shows that 2,6FBP gives a 
linear competitive plot with respect to F6P. The slope replot shown in 
Figure 3 is also linear. Similarly, inhibition with respect to P^ is 
linearly competitive with a linear secondary plot, as shown in Figures 2 
and 4, respectively. The values for the inhibition constants were 
determined to 1.16 ± 0.16 yM for F6P and 0.35 ± 0.06 wM for P^ from 
Figures 1 and 2, respectively. Though theoretically the inhibition 
constants should be equivalent, some error may be introduced because 
they are calculated by using a compilation of other previously 
determined kinetic constants (54), in addition to the experimental data. 
In the presence of saturating Mg^^, the reverse reaction of FBPase 
is Bi Uni. The kinetics of the reverse reaction have been investigated 
by initial-velocity studies and the use of substrate and product analogs. 
Fromm and Stone showed the product analog 2,5-anhydromannitol-l,6-bis-
phosphate is a competitive inhibitor for both P^ and F6P (54), as well 
as a competitive inhibitor of FBP (52). These data served to eliminate 
both steady-state Ordered Bi Uni and Ping Pong Bi Uni mechanisms because 
the rate equation for both predicted that the analog would be a 
noncompetitive inhibitor with respect to F6P. However, the data still 
were consistent with two mechanisms described by the rate equation; 
Figure 1. Plot of the reciprocal of initial velocity versus the 
reciprocal of the molar concentration of F6P in the 
absence (o ) and presence of 1.5 yM ( • ), 3.0 uM ( x ), 
4.5 uM (A), and 6.0 uM (•) 2,6FBP. Assays were performed 
as outlined in "Materials and Methods" with a fixed 
concentration of 25 mM P^ and 0.60 I.U. of FBPase 
2.0 
Figure 2. Plot of the reciprocal of initial velocity versus the 
reciprocal of the molar concentration of in the 
absence (o) and presence of 1.5 HM (•), 3.0 uM iO), 
4.5 uM (A), and 6.0 uM ( • ) 2,6FBP. Assays were performed 
as outlined in "Materials and Methods" with a fixed 
concentration of 0.61 mM F6P and 0.33 I.U. of FBPase 
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Figure 3. The slope replot for 2,6FBP inhibition of FBPase with respect 
to F6P. The data are from Figure 1 
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Figure 4. The slope replot for 2,5FBP inhibition of FBPase with respect 
to P^. The data are from Figure 2 
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where Kg, Kp, and are the Michaelis constants for and F5P, and 
the dissociation constant for the product analog. In previous work on 
the forward reaction, F6P was shown to be a noncompetitive inhibitor for 
FBP. Because product inhibition should be competitive for a rapid-
equilibrium random Uni Bi mechanism, it is necessary to propose the 
formation of an inactive enzyme•FBP•F6P complex for this mechanism to be 
in harmony with all the data. 
An equally likely mechanism of the type proposed by Frieden (59) 
was illustrated in scheme 3. This rapid-equilibrium Ordered mechanism 
involves the formation of an inactive enzyme-FSP complex, and is 
consistent with all the data obtained to this point for the reverse 
reaction. 
The two aforementioned mechanisms are not distinguishable by 
classical kinetic techniques. It has been pointed out, however, that 
three criteria will permit a differentiation to be made between the 
rapid-equilibrium Random mechanism and the unique Ordered mechanism (60). 
One such procedure involves the use of a multisubstrate analog. For a 
Random mechanism, the multisubstrate analog would be a competitive 
inhibitor for both substrates. Because the analog would bind both 
substrate sites on the enzyme simultaneously, only the enzyme term of 
the rate equation would be affected. Primary plots for this mechanism 
would be linearly competitive, and secondary plots would be slope 
linear. . 
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Alternatively, in the case of Frieden's mechanism, the analog would 
be expected to bind to a subsite for F6P, as well as to the active site. 
The binding of more than one molecule of the analog per substrate site 
will result in several squared terms in the rate equation (111). 
Consequently, the primary plots for this mechanism would be competitive 
for and noncompetitive for F6P, and secondary plots would be 
parabolic. 
It is well-documented that 2,6FBP is a potent competitive inhibitor 
of FBPase in the forward reaction, and the compound seemed an ideal 
choice as a multisubstrate analog for F6P and P^. The results of our 
study on the effect of 2,6FBP indicate that it is a powerful inhibitor 
of the reverse reaction as well. In light of the previous discussion, 
it also is possible to select the steady-state Random Uni Bi mechanism 
in which the rapid-equilibrium assumption is approximated (54) as the 
best possibility for FBPase in the forward direction. In the reverse 
direction, FBPase seems to be rapid-equilibrium Bi Uni. 
The nature of the actual interaction of 2,6FBP with FBPase is far 
from clear. At low concentrations (< 10 uM), 2,6FBP seems to be 
strictly a competitive inhibitor of the forward reaction; however, 
higher concentrations of 2,6FBP cause the hyperbolic substrate 
concentration curve to become sigmoidal (3). In addition, even at low 
concentration, the effector potentiates AMP inhibition. Hence, it has 
been proposed that the action of 2,6FBP on FBPase involves at least some 
interaction with an allosteric site (3). 
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It is possible to conceive of two mechanisms for 2,6FBP interaction 
with FBPase that are in harmony with the data presented here. If the 
effector were to interact only with the active site, we would expect 
competitive plots for both substrates and linear replots as seen in 
Figures 1 and 2. This would, however, be kinetically indistinguishable 
from a situation in which 2,6FBP binds exclusively to an allosteric 
site, causing simultaneous release of product or substrates at the 
active site. 
On the basis of the previous study of the effect of the product 
analog 2,5-anhydromannitol-l,6-bisphosphate on the reverse reaction, 
interaction with the active site seems most likely. The product analog, 
thought to act at the FBP active site, gave kinetic plots of the same 
pattern seen with 2,6FBP. It also is possible that 2,6FBP binds an 
allosteric site only at concentrations higher than were used in this 
study. 
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CONCLUSIONS 
The results of this study indicate that the kinetic mechanism of 
bovine liver FBPase in the reverse reaction direction is rapid-
equilibrium Bi Uni. In addition, the inhibition patterns produced by 
2,6FBP with respect to F6P and in the reverse direction FBPase 
reaction are indicative of an active site mode of action for the 
inhibitor. However, as mentioned, an allosteric mode of action of 
2,6FBP is also a possibility. Clearly though, 2,6FBP acts at only one 
type of site, because the results present no evidence of multiple 
binding of the inhibitor to the enzyme. In any case, physical studies 
on the binding of 2,6FBP to FBPase presented in the following section 
serve to clarify the nature of the interaction. 
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PART II. NUCLEIAR MAGNETIC RESONANCE STUDIES OF FRUCTOSE 
2,6-BISPHOSPHATE AND ADENOSINE-5'-MONOPHOSPHATE 
INTERACTION WITH BOVINE LIVER FRUCTOSE 
1,6-BISPHOSPHATASE 
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INTRODUCTION 
Bovine liver fructose 1,6-bisphosphatase, FBPase (EC 3.1.311), 
catalyzes the hydrolysis of fructose 1,6-bisphosphate (FBP) to fructose 
6-phosphate (F6P) and inorganic phosphate (P^) in the presence of a 
required divalent metal ion (Mn^+, Zn^"*", Mg^*). The enzyme is composed 
of four identical subunits, each capable of binding metal ions (23). 
FBPase plays a key role in the futile cycle of FBP synthesis and 
degradation and is highly regulated by several cellular components, 
including AMP and fructose 2,6-bisphosphate (2,6FBP) (for reviews 
see 9-11). 
Inhibition of FBPase by 2,6FBP in the direction of FBP degradation 
has been characterized as being synergistic with AMP and is relieved by 
high concentrations of the substrate, FBP (3,66). However, the 
inhibitor, 2,6FBP, has also been reported to change the substrate 
saturation curve from hyperbolic to sigmoidal (66). As described in 
Part I, in the reverse direction, the inhibitor gives kinetic results 
consistent with classical competitive inhibition, indicating that 2,6FBP 
acts either exclusively at the active site or solely at an allosteric 
site. Competitive inhibition in the forward direction also has been 
reported for FBPase from pig kidney (67), spinach chloroplast (67), and 
rabbit liver (118). In addition, Kitajima and Uyeda (69) have reported 
that 2,6FBP binds only one site per FBPase monomer and that binding of 
the inhibitor is competitive with F6P, P^, and FBP. Similarly, rat 
liver FBPase binds only one equivalent of 2,6FBP per enzyme monomer, and 
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the substrate analog aMeFBP blocks 2,5FBP binding (68). These results, 
however, could also be interpreted either as 2,6FBP action at the active 
site or binding of the inhibitor at an allosteric site, which prevents 
the binding of substrate or products. 
To establish whether 2,6FBP acts at the active site or at an 
allosteric site of FBPase, we have taken advantage of the Mn-binding 
property of the enzyme by monitoring the effect of the paramagnetic ion 
on NMR relaxation rates. Cunningham et ai. (110) have utilized this 
technique to map the active and allosteric site topography of rabbit 
liver FBPase for the phosphoryl groups of F6P, P^, and AMP and the 
protons at carbons 2, H(2), 8, H(8), and 1, H(l) of AMP. In a similar 
fashion, I have measured enzyme-Mn to phosphorus distances for FSP and 
Pj^, products of FBPase that are considered to bind only at the active 
site, and I have compared these with the distances obtained for the C-2 
and C-6 phosphate groups of 2,5FBP and the C-1 and C-5 phosphate groups 
of a-methyl D-fructofuranoside 1,6-bisphosphate (aMeFBP), a nonhydro-
lyzable competitive inhibitor of FBPase (51). A strong correlation of 
these distances would indicate that 2,6FBP also acts at the active site 
of FBPase. In addition, a second locus for the distance measurements 
can be introduced by spin-labelling the enzyme with a nitroxide group at 
an active sulfhydryl site because it has been established (23) that 
bovine liver FBPase has one very reactive thiol group per enzyme 
monomer. 
The synergism of inhibition observed for AMP and 2,6FBP suggests 
that the sites for these inhibitors may be closely associated. By 
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comparing the enzyme-Mn to phosphorus distances of one inhibitor in the 
presence and absence of the other, it is possible to observe perturba­
tions of the AMP site produced by the presence of 2,6FBP or vice versa. 
The effect of 2,6FBP on the binding of ^'*C-AMP to FBPase is also 
investigated. 
AMP is thought to act at an allosteric site of FBPase, as evidenced 
by the ability of several chemical modifiers to disrupt AMP sensitivity 
without inhibiting enzyme activity (9). AMP inhibition of the bovine 
liver FBPase has been investigated for both the forward and reverse 
direction reactions by using initial-rate and progress-curve-analysis 
kinetic techniques (55). The nucleotide was found to exhibit noncom­
petitive inhibition with respect to the substrates in both directions. 
Though the interaction of AMP with FBPase has been thoroughly 
studied by classical kinetic and binding techniques, additional 
information about the dynamics of the nucleotide-enzyme complex 
formation could be gleaned through the use of NMR to monitor the 
exchange reaction between AMP and enzyme. The use of NMR to study the 
binding of small molecules to macromolecules has been described in 
detail (4-6,92-98). In this section, NMR was used to obtain 
information on reaction rate constants and activation parameters for the 
AMP interaction with FBPase in the presence and absence of 2,6FBP. 
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MATERIALS AND METHODS 
FBPase from fresh bovine liver was prepared as described in Part I. 
The enzyme was then concentrated by ammonium sulfate precipitation and 
dialyzed against the appropriate buffer for the experiments as detailed 
below. 
2,6FBP was prepared as described in Part I and assayed by acid 
hydrolysis for F6P release. The concentration of F6P was determined 
enzymatically by using phosphoglucoseisomerase and glucose-6-P 
dehydrogenase and monitoring the absorbance at 340 nm of NADPH produced 
from NADP+. AMP concentrations were determined by measuring the 
absorbance at 259 nm, using an extinction coefficient of 15,400 cm~^. 
Mg^"*" and Mn^^ stock solutions were standardized by the Analytical 
Service Division of the Ames Laboratory of the United States Department 
of Energy, Ames, Iowa- [^''Mn] MnClg was obtained from New England 
Nuclear, and ^"*0 AMP was from Amersham. 
Preparation of aMeFBP 
The synthesis of oMeFBP by phosphorylation of a-methyl fructoside 
was previously described (51). The method involves methylating 
fructose, and separating the resulting a and 6 anomers by selective 
crystallization of the anomeric complexes with brucine alkaloid (51,119). 
Separation of the methylated anomers of fructose by this method was 
found to be unsatisfactory in my hands; indeed, Benkovic et ai. (51) 
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also reported difficulty isolating a product, presumed by them to be 
a-methyl fructoside, which gave optical rotation results inconsistent 
with the literature values (119). Therefore, a-methyl fructose was 
separated from g-methyl fructoside by using column chromatography (120) 
before phosphorylation of the a anoroer, as described in detail below. 
Fructose (5.2 g) was treated with anhydrous, acid methanol (125 ml 
methanol plus 0.45 ml concentrated HzSO^) for 48 hours at room 
temperature. The mixture was then neutralized by the addition of 
Amberlite IR-45 (0H~ form), which was removed by filtration. The 
solution was evaporated to obtain 5.0 g of syrup. Hie syrup was 
analyzed by using paper chromatography on Whatman 3MM paper using 
n-propanol: 1 N NH^OH, 7:2 as the solvent (121). The chromatogram 
revealed 3 spots upon treatment with 0.1 N H2SO1, in 90% ethanol followed 
by heating at 70*C for 20 minutes. One spot had the same mobility as 
fructose, whereas the other spots were more mobile. 
The syrup obtained in the first step was made 50% in methanol and 
applied to a column (3.5 % 50 cm) of Dowex 1X2, 50-100 mesh, in the 0H~ 
form (120). It is imperative that the 50-100 mesh be used, as the 
200-400 grade gives much poorer separation. The column was developed 
with water at a flow rate of 1.5 ml/minute, and 6.0 ml fractions were 
collected. The fractions were analyzed for carbohydrate by the 
phenol-sulfuric acid method (122). lîiree peaks of carbohydrate were 
separated, and the appropriate fractions were pooled and the optical 
rotation determined. The first two peaks eluted from the column gave 
negative optical rotation values, whereas the pool of the third peak 
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gave a value of [a]^^ = +83.9°, in agreement with the literature value 
of +88-93* for a-methyl fructoside (119). Therefore, the peaks were, in 
order of elution, g-methyl fructopyranoside, 6-methyl fructofuranoside, 
and a-methyl fructofuranoside (120). 
The a-methyl fructofuranoside was concentrated by rotoevaporation 
to obtain 0.96 g of syrup, a yield of 18%. Itie syrup was dried for 
12 hours over PgOg in a vacuum desiccator. This material was phosphor-
ylated by using the method described by Hartman and Barker (123) for the 
phosphorylation of 2,5-anhydro-D-glucitol. The syrup (360 mg) was taken 
up in 10 ml of dry pyridine at -20°C, and 0.9 ml diphenylphosphoryl-
chloridate was added. After 30 minutes, the temperature was raised to 
0°C, and the mixture was incubated for 12 hours. The reaction was 
stopped by the addition of a few drops of water, and 50 ml of chloroform 
were added. The chloroform solution was washed successively with two 
200 ml portions of 1 N H2SO4, followed by similar washes with saturated 
sodium bicarbonate, and finally, water. The resulting solution was 
evaporated to a syrup (approximately 1 g, 80% yield). 
The syrup was taken up in 50 ml of methanol, and the phenyl groups 
were removed by catalytic hydrogénation. Platinum oxide (0.2 g) was 
added to the solution, which had been flushed with nitrogen. H2 was 
bubbled through the solution for 12 hours, after which the catalyst was 
removed by filtration. The sample was evaporated, and the resulting 
syrup was taken up in 10 ml water. The solution was adjusted to 
pH 10.00 with cyclohexylamine and sufficient acetone was added to form a 
precipitate. The solution was stored overnight to allow the formation 
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of crystals, after which the crystallization was repeated. Approximately 
0.5 g of material was collected, for a final yield of 30%. 
Paper chromatography (121) of the final product revealed one spot 
when the chromatogram was treated to reveal carbohydrate, and two spots 
when treated to reveal phosphorus-containing material (124). The aMeFBP 
was further analyzed by and ^^P NMR. ^^P NMR revealed two major 
and one minor resonances. The minor resonance was identical to that 
obtained with commercial methyl phosphate, and composed approximately 
10% of the total phosphate in the sample. The two major resonances were 
assigned to the 1 and 6 phosphate groups of aMeFBP based on comparison 
to FBP and 2,6FBP (117,125). The structure of the oMeFBP was confirmed 
by using and NMR, and comparing my results to those published 
previously (125-127). 
The cyclohexylammonium salt of aMeFBP was converted to the sodium 
form by using ion exchange resin (Dowex 50W-X8). The concentration of 
the aMeFBP was determined by measuring total phosphate as described by 
Hartman and Barker (123). 
Preparation of Spin-labelled ETBPase 
Spin-labelled FBPase was prepared in a fashion similar to that 
described by Cunningham et ai. (110). The maleimide spin label 
(3-[Maleimidomethy]-proxyl, Sigma) was dissolved in 50 mM PIPES buffer, 
pH 6.5, to a concentration of 2 mg/ml. FBPase (50 wmoles) was incubated 
with a ten-fold molar excess of the spin label for 2 hours in the dark 
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at room temperature. The number of FBPase sulfhydryl groups modified 
was determined before and after spin-labelling by reaction with Ellman's 
reagent (5,5-dithiobis-2-nitrobenzoic acid, DTNB, Sigma) (128). For 
this reaction, 2 yM FBPase was added to a 20-fold excess of DTNB in 
0.1 M Tris, pH 8.0, in a total volume of 1.0 ml, and the change in 
afasorbance at 412 nm was monitored. Before spin-labelling, four 
sulfhydryl groups per enzyme tetramer reacted with the DTNB over a 
period of five minutes. This was followed by a very slow reaction of 
1-2 additional groups over the next 2 hours. After spin-labelling, only 
the slow reacting sulfhydryl groups remained. Spin-labelled FBPase 
retained over 75% of the activity of the native enzyme. 
All reagents used were of the highest purity available commercially. 
All solutions, including enzyme, used in NMR experiments were treated 
with Chelex before the addition of the appropriate metal ion. 2,6FBP, 
F6P, Pj^, aMeFBP, and AMP stock solutions were adjusted to pH 6.5 before 
their addition to NMR samples. NMR tubes were acid washed and 
thoroughly rinsed before use. Distilled, deionized water was used 
throughout. 
Methods 
Measurements were made with a Bruker HM-300 NMR spectrometer 
operating at 121.5 MHz for ^^P and 300 MHz for ^H. The 300-MHz 
spectrometer is equipped with a variable temperature controller and an 
Aspect 2000 computer. All experiments were performed at 10®C unless 
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otherwise noted. Irradiation of the water resonance was used in the 
NMR exchange broadening experiments. In the NMR experiments, 
broadband decoupling, if used, was gated by using an automated pulse 
sequence to avoid a Nuclear Overhauser Effect. 
Longitudinal relaxation rates, Tj, were determined by using an 
i80®-T-90° inversion-recovery pulse sequence and computer fitted to the 
equation Y = A3 + A2 exp(%/Ti), where Y is the normalized peak intensity 
for a particular value of x, A2 is the nucleus flip angle in units of 
tt/2, and A3 is the normalized intensity of the largest peak. The 
transverse relaxation rates, Tg, were measured by obtaining the line 
width at half height in hertz. A, and applying the equation I/T2 = uA. 
Samples for the distance measurements typically contained 13.5 mM 
F6P, aMeFBP, 2,6FBP, Pj_, or AMP in 50 mM PIPES (pH 6.5) and 20% DgO to 
serve as a heteronuclear lock. When distance measurements were 
performed on two compounds in the same sample (i.e., AMP and F6P or AMP 
and 2,6FBP), both compounds were present at 13.5 mM. Either Mn^"*" or 
Mg^"*" was allowed to incubate with FBPase several hours at 5°C before 
addition to the sample. The final concentration of FBPase tetramer in 
the samples was 1.2 yM, whereas the concentration of metal ion was 
either 2.4 yM or 3.6 yM. When spin-labelled FBPase was used in place of 
Mn-FBPase in distance measurement experiments, the concentration of 
enzyme was 20 yM tetramer. Other conditions were identical to those 
described for experiments using Mn-FBPase. 
Exchange measurements made for the H(2) and H(8) of AMP were 
performed in 99% D2O containing 25 mM PIPES (pH 6.5), 6 mM Mg^"*", and 
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0.1 mM EDTA. Other conditions for these experiments are given in the 
figure legends. 
Tj and T2 measurements for the H(2) and H(8) of AMP were performed 
on samples containing 99% DgO, 50 mM PIPES (pH 6.5), 13.5 mM AMP, and 
1.2 uM FBPase tetramer preincubated with metal as just described. 
All and Tg determinations were made at least twice and usually 
three times. Agreement between determinations was ±20%. 
Ti determinations at 36.4 MHz were made on a Bruker HX-90 
spectrometer. 
Distance Measurements 
The distances between enzyme-bound Mn^^ or nitroxide spin label and 
the phosphate groups of the various effectors of FBPase were obtained by 
monitoring the effect of the paramagnetic centers on the longitudinal 
relaxation rates of the ^^P nuclei of the ligands. The distances were 
calculated by a modified form of the Solomon-Bloembergen equation (101): 
r (A) = 
1/6 
where f is the mole fraction of enzyme-bound ligand, is the correla­
tion time for the dipolar interaction, uj is the Larmor precession 
frequency, and T^p is determined using the equation 1/Tip = 1/Ti 
- l/Ti(Mg)- C equals [(2/15) Yi^g^S^S(S+l)]where Yi is the 
gyromagnetic ratio, g is the electronic g-factor, S is the electron 
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spin, and B is the Bohr magneton. For ^^P-Mn interactions, C has a 
value of 601, and for ^^P-nitroxide interactions, C has a value 
of 399 (5). 
Dialysis Experiments 
The concentration of Mn-enzyme and the concentration of Mn^"^ free 
in solution were measured by using an equilibrium dialysis cell and 
^^Mn. The dialysis cell consists of two Plexiglas chambers, each 
capable of containing 1 ml. The chambers can be separated by a small 
piece of dialysis tubing, and clamped together. (A size 14 cork borer 
can be used to conveniently cut the dialysis tubing to the proper size.) 
Solutions may then be added to each chamber through a small port by 
means of a syringe. The ports are sealed with tape, and small molecules 
may exchange between the two chambers through the separating membrane. 
FBPase was incubated for 1 hour at 5°C with two equivalents of 
[^^Mn]MnCl2, 20 uCi/wmole, as for the NMR experiments. To each chamber 
of the equilibrium dialysis cell was added 0.5 ml of a solution 
containing 13.5 mM PIPES buffer, pH 6.5, and 20% D2O. To one chamber 
was added a small aliquot of Mn-enzyme to a final concentration of 
2.4 uM. The cells were allowed to equilibrate 10 hours at 5°C on an 
agitating platform. To ensure the attainment of equilibrium, a control 
sample was included in which ^""Mn, but not enzyme, was added to one 
chamber. Both sides of the cell were monitored until the ^''Mn 
concentration on each side was equivalent. After equilibration, small 
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aliquots from each side were added to 13 x 100 mm glass culture tubes 
and counted in a Tracer Analytic 1191 gamma counting system. These 
experiments allowed the determination of the concentration of Mn^"*" free 
in solution as well as the concentration of Mn^"*" bound to FBPase under 
the same conditions as those used in the NMR experiments. 
The contribution of binary complexes of the type Mn-ligand to T^p 
was also evaluated by a dialysis experiment. In this case, raPase was 
incubated with 2 or 3 equivalents of Mn^'*' or Mg^"*" as for the NMR 
experiment. Me^^-FBPase was added to a mixture of 13.5 mM ligand, 50 mM 
PIPES pH 6.5 and 20% D2O to give a final concentration of 2.4 uM enzyme 
(twice the concentration used in the NMR experiments) and a final volume 
of 2.5 ml. The sample was transferred to a piece of 6.4 mm dialysis 
tubing and placed in a 1 x 15 cm glass tube containing 2.5 ml of the 
same mixture minus FBPase. The top of the tube was sealed with 
laboratory film, and the tubes were attached to an agitating platform 
and allowed to equilibrate for at least 4 hours. The exact time needed 
for equilibration was determined by including a control sample which was 
assembled as described, except that AMP was added only to the sample 
inside the dialysis sack. The outside solution was then monitored by 
removing small aliquots and determining the AMP concentration by using 
the absorbance of the sample at 259 nm. A 5 mm acid-washed glass bead 
placed in the dialysis sack was found to aid in mixing of the sample and 
hence decreased the time needed for equilibration. 
After equilibration, 2.0 ml of the dialysate, containing any 
ligand-Me^"*" complexes but not enzyme, was transferred to an NMR tube and 
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Ti was obtained. For each ligand, both a Mg^"*" and a Mn^"*" sample was 
prepared, so that T^p*, the contribution of binary complexes to Tip, 
could be determined. 
Binding Studies 
Binding experiments were performed at 20°C in duplicate by using 
the method of Paulus (129). PM-10 Diaflow membranes (Amicon) were cut 
with a number 5 cork borer as described and immersed 4 hours in water 
before use. Uniformly labelled ^"^C-AMP was from Amersham. A typical 
experiment contained in a final volume of 200 ul, 50 mM PIPES (pH 6.5), 
6 mM Mg^*, 0.1 mM EDTA, 2 uM FBPase tetramer and AMP (specific activity 
8 yCi/uM) from 1 uM to 50 yM. 2,6EBP or F6P, if present, was at a 
concentration of 50 yM or 0.5 mM, respectively. The samples were 
incubated at 28°C for 5 minutes, then transferred to the Paulus 
apparatus. The Paulus cell was run to dryness under 5-10 lbs/square 
inch of Ng, typically taking 15-30 minutes. The outlet ports were each 
purged with three 5 ml aliquots of ethylene glycol before removal of the 
membranes. The membranes were counted in 1 ml of water and 15 ml of 
Bray's scintillation fluid (130) in a Packard liquid scintillation 
spectrometer with an efficiency of 65%. 
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Exchange-broadening Measurements 
Information on enzyme-bound ligand can be obtained by monitoring 
the broadening of the NMR signal of the small molecule, and the 
Swift-Connick equation can be applied to a system in which a nucleus of 
a ligand exchanges between two environments (100). The observed 
spin-spin relaxation rate, l/Tzobsd' a nucleus undergoing chemical 
exchange between the free and enzyme-bound states is given by: 
l/Tzobsd = l/Tzfree + + '^m^ ' where f is the fraction of ligand 
bound, l/Tzfree is the relaxation rate of free ligand, Tjn, is the 
spin-spin relaxation time in the bound state, and is the lifetime of 
the bound state (l/k^j^gg). The use of this equation requires the 
chemical shifts of the free and bound ligand to be identical and the 
fraction of free ligand to be in excess over the bound ligand (f ( 0.3). 
Either of two exchange mechanisms may describe the ligand-enzyme 
interaction. In the fast exchange limit, Tgn, >> T^J, and the weighted 
average width between bulk and bound inhibitor is observed; however, in 
the slow exchange limit > Tzj,, and the relaxation of the inhibitor is 
governed by the time spent bound to the enzyme, The two exchange 
mechanisms may be differentiated by monitoring the temperature 
dependence of the line broadening. The residence time of the ligand on 
the enzyme, decreases with rising temperature, whereas l/Tzm, which 
is a monotomically increasing function of the correlation time of the 
enzyme-AMP complex for a variety of relaxation mechanisms, should 
decrease with a rise in temperature. 
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Electron Paramagnetic Resonance (EPR) Measurements 
EPR experiments were conducted at 20®C by using a Bruker EP 2000 
spectrometer, operating at 9.78 GHz; 25-yl samples of 228 uM FBPase and 
one equivalent of Mn^"*" were contained in 1.5-mm glass capillary tubes. 
For some experiments, an equimolar (to enzyme tetramer) quantity of 
2,6FBP was included in the sample. For the nitroxide-labelled FBPase, 
Mn^"*" was excluded. 
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RESULTS 
It is possible to measure distances between a paramagnetic probe 
and magnetic nuclei based on that part of the Solomon-Bloembergen 
equations (101) that is characterized by dipole-dipole interactions 
between the electron and nuclear spins provided that certain criteria 
are fulfilled (4-6,92-99). These include (a) a small outer sphere 
contribution to 1/Ti, (b) that l/T^p not be exchange-limited, and 
(c) that the hyperfine contact contribution to l/T^p be very small. 
The restrictions imposed by criterion (a) are minimal because 
outer-sphere contributions, when present, are usually small. 
Criterion (b) is fulfilled by the findings for the T^p/T^p ratios 
illustrated in Table III (5). The last criterion (c) is fulfilled 
because the electron spin relaxation time for Mn^"*" is long, so contact 
contributions to l/Tj by Mn^"*" are nearly always small, especially at 
high magnetic fields. 
The Effect of Mn^'^-FBPase on Relaxation Rates of F6P, 2,6FBP, AMP, 
oMeFBP, and P^ 
The values of fTjp and fT2p obtained for the phosphorus nuclei of a 
number of FBPase ligands in the presence of two or three equivalents of 
metal ion are shown in Table III, along with the enyzme-Mn to phosphorus 
distances calculated from the Solomon-Bloembergen equation by using the 
appropriate T^p values. 
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Table III. Relaxation Rates at 121.5 MHz of FBPase Ligands in Various 
Solutions and Mn-P Distances in FBPase-Mn^^-Ligand Complexes^ 
Ligand [Mn=+] fTip fTip* b fT^p Tip/Tzp r (A) 
(wM) (x IQ-s s) (x 10-s s) (x 10-s s) 
F6P 2.4 
3.6 
27.5 
19.0 
25.4 
20.2 
8.4 
9.1 
32.7 
20.8 
5.3 
5.1 
± 0.4 
± 0.4 
Pi 2.4 
3.6 
28.9 
21.0 
27.8 
22.0 
6.1 
3.7 
47.4 
56.8 
5.4 
5.2 
± 0.4 
± 0.4 
2,6FBP 
2P 2.4 
3.6 
15.4 
11.9 
13.6 9.6 
5.8 
16.0 
20.5 
4.8 
4.7 
± 0.3 
± 0.3 
6P 2.4 
3.6 
14.6 
10.6 
12.8 7.3 
6.4 
20.0 
16.6 
4.7 
4.6 
± 0.3 
± 0.3 
aMeFBP 
IP 2-4 
3.6 
26.5 
23.1 
23.7 6.9 
4.9 
38.4 
47.1 
5.2 
5.2 
± 0.4 
± 0.4 
6P 2.4 
3.6 
20.7 
17.0 
18.5 10.9 
6.6 
19.0 
25.8 
5.0 
4.9 
± 0.4 
± 0.3 
AMP 2.4 
3.6 
5.8 
5.4 
5.2 2.8 
3.3 
20.7 
16.4 
4,1 
4.1 
± 0.3 
± 0.3 
®The concentration of each ligand was 13.5 mM, and the 
concentration of FBPase was 1.2 pM tetramer. Other details are 
described in the text. 
bfTip* is the Tip value corrected as necessary for binary complexes 
(in the case of 3 equivalents of Mn^"*"), and calculated using the values 
of f determined from the data in Table IV (in the case of 2 equivalents 
of Mn^+). 
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The dissociation constants for 2,6FBP (Part I), F6P (7), AMP (55), 
aMeFBP (51), and P^ (7) have been tabulated (131) and, with the 
exception of Pj^, are all <1 mM, confirming that the enzyme is fully 
saturated with these ligands under the experimental conditions 
described. The dissociation constant for P^ is 7.7 mM (7) and the 
enzyme under the conditions used is 65% saturated with P^-
It is known that for Mn^"^ is <1 uM for the binding of the first 
2 metal ions to rabbit liver FBPase (43). The very low Mn^^-enzyme 
dissociation constant suggests that the concentration of Mn^"*" free in 
solution will be quite low. The exact concentration of nonenzyme-bound 
Mn^"*" in the presence of the various ligands was determined by using 
equilibrium dialysis and bovine liver enzyme with 2 equivalents of Mn^"*" 
per tetramer as described in the "Methods" section. The results from 
the experiments are shown in Table IV and indicate that, in all 
instances, more than 85% of the total Mn^"*" is bound to FBPase. These 
values allow the calculation of f, as depicted; in Table IV. 
To determine r(A) in the Solomon-Bloembergen equation, it is 
necessary to take into account contributions to T^p from binary 
complexes of the type Mn^'*'-ligand. With a knowledge of the dissociation 
constants for the four equilibria: E + Mn^"*" = E-Mn^"*", E-Mn^* + ligand 
= E-Mn^'^'-ligand, E + ligand = E-ligand, and Mn^"*" + ligand = Mn^'^-ligand, 
it is possible to determine the distribution and concentration of all 
the species in solution at equilibrium- This information allows one to 
experimentally obtain a complex of Mn^'^'-ligand of comparable concentra­
tion to that which would be expected to be present in the T^ experiments 
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Table IV. Determination of [Mn^"*"] Free^ and the Value of f^ 
Ligand [Mn^"'"] free (wM) f (x 10 **) 
F6P 0.18 1.64 
Pi 0.13 1.68 
2,6FBP 0.29 1.56 
aMeFBP 0.25 1.59 
AMP 0.24 1.09 
8[Mn2+]Free is taken to mean Mn^"*" that is not associated with 
enzyme. 
bpBPase was preincubated with 2 equivalents of ^''Mn^'"'. Other 
experimental details are described in the text. 
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and then evaluate its contribution to T^p determined in the presence of 
enzyme. 
The potential effect of binary complexes to Mn-ligand on flip was 
evaluated by two independent experimental methods. First, Tjp was 
evaluated twice for each ligand in the presence of enzyme incubated for 
2 or 3 equivalents of metal ion. The results of these experiments are 
shown in Table III. For all ligands, with the exception of P^, F6P, and 
2,6FBP, there is no change in the relaxation rates normalized for the 
concentration of metal ion, fT^p, with 3 equivalents of metal ion as 
compared with 2 metal ions- The fT^p values obtained with 3 metal ions 
for Pj^, F6P, and 2,6FBP differ from the respective values obtained with 
2 metal ions by an amount greater than that predicted by experimental 
error alone, indicating either a small contribution of binary complexes 
to the Tip values for these ligands, or a conformational change in the 
enzyme induced by metal. 
An additional set of experiments was designed to evaluate the 
contribution of binary complexes to relaxation rates when two 
equivalents of metal ion were used, as described in the "Methods" 
section. Samples containing ligand and enzyme with 2 equivalents of 
Mnf* or were dialyzed against solutions containing ligand alone. 
Three equivalents of metal ion were used in a separate experiment if 
indications of contributions to T^p from binary complexes existed from 
the previously described experiments (Table III). The outer solution 
was then removed and added to an NMR tube, and a determination 
performed. The results of these experiments are shown in Table V. In 
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Table V. Determination of the Effect of Binary Complexes and Nonenzyme-
Bound Mn^^ on the Relaxation Rates of FBPase Ligands^ 
Ligand [Mn^+]/[FBPase] ^iMn/^^Mg TzMn/TzMg 
F6P 2 1.0 0.9 
3 0.7 0.7 
Pi 2 1.1 1.1 
3 0.7 0.6 
2,6FBP 
2P 2 1.0 0.9 
3 1.0 0.9 
+AMP 2 0.9 1.1 
6P 2 0.9 0.9 
3 1-0 0.8 
+AMP 2 1.0 0.8 
cMeFBP 
IP 2 1.2 1.1 
6P 2 1.0 1.1 
AMP 2 0.9 1.2 
+2,6FBP 2 0.9 1.0 
^The experiments were performed as described in Materials and 
Methods by using 2 or 3 equivalents of Mn^"*" per FBPase tetramer. 
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every instance where 2 equivalents of metal ion were used, the ratio of 
"^1 (Mn)/"^! (Mg) "^2{Mn)/'^2(Mg) equal to or near 1.0, indicating that 
the contributions of binary complexes or free Mn^"*" to relaxation rates 
are negligible in the presence of 2 equivalents of Mn^"*" per enzyme 
tetramer. In the case of F6P and Pj^, the data clearly show contributions 
from binary complexes or free metal ion, when FBPase is equilibrated 
with three equivalents of Mn^"*" or Mg^^; however, a corrected value of 
Tip may be obtained by using the appropriate T],p values from Table III 
and the results of the dialysis experiments, along with the following 
expression: l/fT^p* = l/fT^pg - l/fT^pp, where Tip* is the paramagnetic 
contribution to the longitudinal relaxation rate corrected for free 
metal ion and binary complexes, and Tipg and Tipp are the uncorrected 
value and the contribution from nonenzyme-bound species, respectively. 
Interestingly, the discrepancy between the Tip values for the 2 
phosphorus group of 2,6FBP obtained with 2 or 3 equivalents of metal ion 
does not seem to arise from the existence of either binary complexes or 
free metal ion. Possibly, the binding of metal ion to FBPase causes a 
slight change in the position of the 2 phosphorus group of 2,6FBP 
relative to the active site; however, this effect is not large enough to 
cause significant changes in the value of r, as shown in Table III. 
Because AMP and 2,6FBP are reported to have synergistic inhibitory 
effects, it was of interest to determine if their simultaneous binding 
to FBPase would affect the enzyme-Mn to phosphorus distances of either 
inhibitor. This experiment was accomplished by performing the 
relaxation time determinations in the presence of 13.5 mM concentrations 
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of both AMP and 2,6FBP. As shown in Table VI, there was little change 
in the enzyme-Mn to phosphorus distances for 2,6FBP regardless of 
whether AMP was present or absent; however, the fT^p values for AMP 
showed a large change relative to that obtained in the absence of 
2,6FBP, suggesting that the enzyme-Mn-P distance for AMP had changed 
significantly. Thus, the simultaneous presence of 2,6FBP and AMP on the 
enzyme causes AMP to shift position relative to the active site Mn^"*", by 
a factor of 2 Â. F6P, however, had no effect on the relaxation rates 
determined for AMP. 
To investigate the simultaneous interaction of 2,6FBP and AMP with 
FBPase, binding studies were performed by using one method of Paulus 
(129). The results of these binding studies are shown in Figs. 5 and 6. 
In the absence of 2,6FBP, AMP binding is markedly sigmoidal. This fact 
had been previously reported (33,64). However, these binding studies 
indicate that 2,6FBP has a strong positive effect on AMP binding to 
FBPase, as shown in Fig. 5. Though .the total amount of AMP bound seems 
unaffected, the amount of AMP needed to obtain half-saturation decreases 
from 21 yM in the absence of 2,6FBP to 7 uM in the presence of the 
effector. In addition, 2,6FBP relieves the sigmoidicity of the AMP 
binding curve. F6P had no similar effect, as shown in Fig. 6. 
To further investigate the nature of 2,6FBP inhibition of FBPase, 
samples containing F6P and Mn- or Mg-FBPase were titrated with 2,6FBP, 
and the line width of the phosphorus nucleus of F6P monitored after each 
addition. The results, shown in Fig. 7, suggest that F6P is displaced 
from the enzyme by competition with 2,6FBP. It can be seen from Fig. 7 
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Table VI. Relaxation Rates at 121.5 MHz of 2,6FBP and AMP, and Mn--P 
Distances in FBPase-•Mn^'*'-Ligand Complexes^ 
Ligand fTip 
(X IQ-S s) ( 
fTap 
X IQ-S s) 
Txp/T^p r (A) 
AMP 63 40.5 15.6 6.1 ± 0 .4 
2,6FBP 
2P 21.2 18.1 11.7 5.1 ± 0 .4 
6P 22.3 18.3 12.2 5.2 ± 0 .4 
®The concentration of both ligands was 13.5 mM. FBPase 
concentration was 1.2 uM tetramer. Other details are described in the 
text. 
Figure 5. Binding of AMP to FBPase in the absence (•) or presence (o) 
of 50 yM 2,6FBP at 20°C. Other conditions were as described 
in Methods 
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Figure 6. Binding of AMP to FBPase in the absence (•) or presence (o) 
of 0.5 mM F6P at 20°C. Other conditions were as described in 
Methods -
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Figure 7. The effect of variable concentrations of 2,6FBP on the reciprocal of the line 
width (v) of the phosphate group of F6P in the presence of Mn-FBPase (o) or 
Hg-FBPase {•). The concentration of F6P was 10 mM, and other conditions were as 
described for the distance measurements. 
0.15 
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mM 2,6FBP 
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that the line width of the Mn-FBPase sample approaches that of the 
control sample containing Mg-FBPase with increasing concentrations of 
2,6FBP. In addition, the linearity of the plot is characteristic of 
competition between the two ligands for a site on FBPase, presumably the 
active site (132). To further substantiate these results, the of the 
F6P phosphorus nucleus was obtained before and after the addition of 
2 mM 2,6FBP. The fT^p values obtained before and after 2,6FBP addition 
were 2.00 x 10"** s and 20.2 x 10"** s, respectively. This distinct 
change in the flip values is, again, indicative of displacement of F6P 
from the enzyme by 2,6FBP. Thus, the NMR experiments described in this 
report give results that are in harmony with kinetic and binding studies 
which have shown that 2,6FBP and F6P interact in a mutually exclusive 
fashion with FBPase. 
Determination of Correlation Times in Mn-FBPase Complexes 
To calculate intemuclear distances from the T^p values given in 
Table III, a value of the correlation time for the dipolar effect of 
Mn-FBPase on the nuclei of the various ligands, must be determined. 
Estimates of the value of were obtained by three independent methods. 
In the first instance, the correlation time was estimated by using 
the Tip/Tzp ratio for the H(8) of AMP at 300 MHz and applying the 
equation: 
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Tip = 4 + 3/(1 + 
Tzp 6/(1 + 
Tip/Tzp had a value of 8.1, and the correlation time calculated was 
1.7 X 10"^ s. Similarly, the T^p/Tgp ratio for a proton resonance 
arising from 2,6FBP was 22.2, giving a value of 2.98 x 10~® s for the 
correlation time. 
The same method was applied to the T^p/Tzp ratios for all the 
experiments. The T^p/Tgp ratio average was greater than 26. This value 
is somewhat larger than those obtained by other methods, suggesting 
scalar effects on the Tg value, which increase the magnitude of the 
Tip/T2p ratio. The correlation times determined from these data were 
not used in the distance measurement calculations. 
A second estimate of was obtained from the Tip values for the 
phosphate of F6P determined at 121.5 MHz and 36.4 MHz, assuming that 
is frequency dependent. The ratio of Tip for F6P at the two frequencies 
was 40, and a lower limit value of calculated from the Bloembergen-
Morgan equation (133) as modified by Fung et ai. (103), is 3.0 x 10"^ s. 
Another estimation for the correlation time was obtained by 
measuring the peak to peak separation of an EPR transition of enzyme-
bound Mn^"*" and applying the equation: 
l/Tzg = [Tidine width) g (3)^^^]/(7.1 x lO"?) Gs 
where g has a value of 2. Assuming that Tjg, the electron-spin 
relaxation time for Mn^'^'-FBPase, is equal to tj,, the line width of 
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34.5 G results in a correlation time of 1.88 x 10~® s, a lower limit. 
When 2,6FBP was included in the sample, the line width was 36.7 G, and 
the resulting correlation time was 1.78 x 10"^ s. 
An average correlation time of 2.0 x 10"^ s was used in the 
Solomon-Bloembergen equation to calculate Mn-enzyme to phosphorus nuclei 
distances. 
Nitroxide-^ip Distance Estimations 
The effect of spin-labelled FBPase on the spin lattice relaxation 
times of the phosphorus nuclei of 2,6FBP and F6P was negligible, as 
evidenced by a <20% difference in the Tj values obtained in the presence 
of native or spin-labelled FBPase. Therefore, it was not possible to 
determine the distance between the phosphorus nuclei of either ligand 
and the nitroxide spin label. However, a minimum distance (>9.1 A) can 
be estimated by using a correlation time of 4 x 10"^ s, obtained by 
using EPR. 
Exchange-broadening Measurements for H(2) and H(8) of AMP 
Fig. 8 shows the dependence of the line widths of resonances 
arising for H{2) and H(8) of AMP on f, the fraction of AMP bound to 
FBPase. No chemical shift changes were observed for either proton 
resonance upon binding to the enzyme. Because the changes in line 
widths observed for the various values of f were rather small, two 
Figure 8. Plot of the change in H(8) (•) and H(2) (o) linewidths (v) of 
AMP in the presence of 0.12 mM FBPase tetramer (0.24 mM AMP 
sites) as a function of f, the fraction of AMP bound at 15°C. 
(A) Denotes an upfield buffer resonance, as described in the 
text. The total AMP concentrations varied from 0.8 mM to 
4.8 mM. Spectra were obtained in 99% DgO containing 25 mM 
PIPES (pH 6.5), 6 mM Mg2+, and 0.1 mM EDTA 
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control experiments were carried out to ascertain if the changes in line 
widths are indeed due to specific AMP binding to FBPase rather than to 
changes in viscosity caused by the introduction of AMP into the enzyme 
solution. First, the line width of an upfield resonance arising from a 
buffer component was monitored at each value of f and showed little 
change throughout the experiment. Second, a sample made up with a value 
of f = 0.3, but containing heat-denatured enzyme, gave a narrow line 
width (<3 Hz) for both proton resonances. 
Fig. 9 shows the variation in line width of the H(8) and H(2) of 
AMP as a function of temperature. Between 5°C and 30°C, these line 
widths narrowed, indicating that AMP is in fast exchange on the NMR 
time scale between free and bound environments, and, therefore, that 
T2JJ >> Tjj. These results are in harmony with the findings shown in 
Table III for AMP, which suggest that AMP is in the fast exchange limit. 
From the temperature dependence of the line broadening of the proton 
resonances, it is possible to obtain the apparent energy of activation 
(Eg) of AMP from an Arrhenius-type plot as shown in Fig. 10. The values 
of Eg and of AMP association with FBPase for H(2) and H(8) of AMP 
obtained from the slope of the Arrhenius plot are 1.54 Kcal/mole and 
1.76 Kcal/mole, respectively. 
Because the fast exchange region is indicated by the data 
presented, Tg^^ >> tjj, and it is possible to determine a lower limit for 
the dissociation rate constant, , inasmuch as = l/k^^j^gg. The 
average value of Tz^ was 5.0 x 10"^ s, and the lower limit of k^igg is 
therefore 0.2 x 10^ s~^. 
Figure 9. Variation of the linewidths (Av) of the H(8) (•) and H(2) (o) resonances of AMP as a 
function of temperature. The sample contained 0.17 mM FBPase tetramer, 1.2 mM AMP, 
25 mM PIPES (pH 6.5), 6 mM Mg2+, and 0.1 mM EDTA in 99% DjO. 
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Figure 10. Arrhenius plot of the temperature dependence of specific 
broadening of the H(8) (•) and H(2) (o) resonances of AMP. 
The data are from Figure 9. 
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An additional set of experiments was designed to determine if 
2,6FBP would produce measurable effects on the H{2) and H(8) resonances 
of AMP. Fig- 11 shows the proton resonances in the presence and absence 
of 2,6FBP. Clearly, the addition of 2,6FBP causes the AMP resonances to 
sharpen markedly, although no chemical shift was observed. The simplest 
explanation for this observation would be attributed to a competition 
for a particular binding site between the two compounds. This was 
unlikely in the present situation because of the dissimilarity of the two 
compounds and the accumulated evidence indicating that 2,6reP promotes 
the binding of AMP on FBPase (68,69,Fig. 5). 
It was possible that the AMP line narrowing observed in the 
presence of 2,6FBP was due to a change in the exchange mechanism of 
AMP-enzyme complex formation. To investigate this possibility, 
a variable-temperature experiment identical to that shown in Fig. 9 
was performed, except that 0.5 mM 2,6FBP was included in the 
sample. Throughout the experiment, the line width of H(2) remained 
within ± 0.1 Hz of an average value of 1.70 Hz, and the line width of 
H(8) remained within ± 0.3 Hz of 2.05 Hz. This indicates that either a 
fast or an intermediate exchange mechanism describes the AMP-enzyme 
complex formation because no line broadening occurred with elevated 
temperature. 
Figure 11. NMR spectrum of H(8) and H(2) of AMP in the absence (A) 
and presence (B) of 2,6FBP. (A) Spectrum of a sample 
containing 0.17 mM FBPase tetramer, 1.2 mM AMP, 25 mM PIPES 
(pH 6.5), and 0.1 mM in 99% DjO. 
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DISCUSSION 
The objective of this study was to investigate the enzyme-ligand 
interaction of two potent inhibitors of FBPase, 2,6FBP, and AMP. Of 
particular importance was the nature of the site occupied by 2,6FBP and 
how this site interacts, if at all, with the allosteric site of AMP. 
Although Cunningham et al- (110) have made distance measurements 
using the technique of paramagnetic ion enhancement of relaxation rates 
of magnetic nuclei with rabbit liver FBPase, it was necessary for us to 
duplicate some of their experiments with the bovine liver enzyme for at 
least two reasons. First, the two enzymes do differ in both chemical 
and kinetic properties. For example, the two enzymes are immunologically 
different (22), the bovine enzyme contains tryptophan, whereas the 
rabbit enzyme lacks this amino acid (23), and finally, rabbit liver 
FBPase is believed to be kinetically irreversible (58), whereas the 
reverse reaction kinetics of the bovine enzyme have been studied in 
detail (7). Thus, it could not be assumed, a priori, that the results 
of (110) are applicable to bovine liver FBPase. Second, it was 
necessary to establish the distances from Mn^"*" on bovine liver FBPase to 
the active and AMP binding sites as a point of reference for the 2,6FBP 
binding locus, which is the basis for this report. It will be shown 
that, although the topography of the two FBPases is similar relative to 
their substrate and AMP binding sites in some respects, they do differ 
in other important characteristics. 
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Despite numerous studies on the interaction of 2,6FBP with FBPase 
since the discovery of the inhibitor in 1981, there still is controversy 
over whether the inhibitor acts at an allosteric site or the active site 
of the enzyme. Inhibition of the rat liver FBPase by 2,6FBP was 
reported by Pilkis et al. (2) and Van Schaftingen and Hers (1). Both 
groups describe the inhibition as being synergistic with AMP; however, 
Pilkis et al. (3) reported purely competitive inhibition, whereas Van 
Schaftingen and Hers (66) indicated that the inhibitor changes the 
substrate-saturation curve from hyperbolic to sigmoidal, suggestive of 
an allosteric mode of competition. Pilkis et ai. (3) were later able to 
confirm the latter result with the rat liver FBPase. However, Gottschalk 
et al. (67) have since reported exclusively competitive inhibition for 
pig kidney and spinach chloroplast FBPases, and Pontremoli et ai. (134) 
have reported competitive inhibition of rabbit liver FBPase by 2,6FBP. 
The reverse reaction kinetics of the inhibition of bovine liver 
FBPase gave results indicative of classical linear competitive 
inhibition with respect to F6P and P^ by 2,6FBP (Part I). These 
findings are consistent with the action of 2,6FBP at either the active 
site or an allosteric site of FBPase, but not both. If 2,6FBP does in 
fact bind to an allosteric inhibitory site, then binding of substrate 
does not occur at the active site; i.e., binding of the ligands is 
mutually exclusive. 
Kitajima and Uyeda (69) have investigated the binding of 2,5FBP to 
rabbit liver FBPase by using a column centrifugation technique. Their 
results indicate the inhibitor binds to a single site on each enzyme 
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monomer and that binding of 2,6FBP can be prevented by F6P, P^, and FBP. 
2,6FBP (69) and FBP (43) both produce nonlinear Scatchard plots at 
higher ligand concentrations; however, the substrate and inhibitor may 
differ in the degree of cooperativity expressed (69). 
The binding of 2,6FBP to rat liver FBPase also has been investi­
gated (68). In this study, 4 moles of 2,6FBP were found to bind per 
enzyme tetramer, and 2,6FBP enhanced the binding of AMP to the enzyme. 
In addition, the substrate analogs oMeFBP and BMeFBP prevented the 
binding of 2,6FBP to FBPase, indicating an active site mode of binding 
of 2,6FBP. 
2,6FBP protection of the catalytic activity of pig kidney (67) 
and rabbit liver (134) FBPases from inactivation by pyridoxal 5'-phos­
phate has been demonstrated, indicative of an active site mode of 
binding for the inhibitor. On the other hand, 2,6FBP protects both the 
catalytic activity and AMP allosteric site of the rat liver FBPase from 
acetylation, whereas FBP protects only the catalytic activity (135). In 
addition, 2,6FBP, but not FBP, confers protection from proteolysis on 
the rabbit liver enzyme (134). Also, protection of the catalytic 
activity of rat liver FBPase is given by low concentrations of 2,6FBP, 
or high concentrations of the substrate (136). Furthermore, Gottschalk 
et ai. (67) have reported the catalytic activity and sensitivity 
to2,6FBP inhibition of pig kidney FBPase to have similar pH profiles, 
whereas Francois et al. have found that the inhibitory action of 2,6FBP 
decreases with the increasing pH, though the affinity for substrate is 
not affected by the same conditions (137). One recent report (138) has 
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even suggested that 2,6FBP is an activator of rat liver FBPase, as well 
as an inhibitor. Thus, the accumulated evidence presented in reports on 
2,6FBP interaction with several FBPases does not clearly point to a 
particular mode of binding of the inhibitor. 
From experiments presented in this study, estimates of the distances 
from the Mn-binding site on bovine liver FBPase subunits to the 
phosphorus atoms of F6P, P^, AMP, aMeFBP, and 2,6FBP have been obtained. 
A direct comparison of the enzyme-Mn to phosphorus distances obtained for 
the C-6 phosphorus atoms of F6P, aMeFBP, and 2,6FBP gives an indication 
of the identity of the site(s) occupied by the compounds. Had the 
distances been significantly different, an allosteric site for 2,6FBP 
would have been strongly indicated. Because the three distances are 
within experimental error, identical, the experiments described herein 
present circumstantial evidence that 2,6FBP occupies the active site of 
FBPase, as do F6P and aMeFBP. Of course, the possibility remains that 
F6P, P^, aMeFBP, and 2,6FBP occupy separate sites, which coincidentally 
have the same Mn-phosphate distances. However, the distance between 
enzyme-bound Mn^"*" and the C-1 phosphorus atom of oMereP, the C-2 
phosphorus atom of 2,6FBP, and P^, are also identical. These results add 
credence to the hypothesis of an active site mode of action for 2,6FBP. 
The results suggest that the FBPase site for the phosphorus groups 
of various sugars, as well as P^, is quite static, as evidenced by the 
similarity of the enzyme-Mn to phosphorus distances observed for F6P, 
P^, aMeFBP, and 2,6FBP. The relative positions of 2,6FBP, F6P, aMeFBP, 
and P^ to Mn^"*" at the active site of FBPase are diagrammed in Figure 12. 
Figure 12. Relative spatial arrangements between F6P, oMeFBP, 2,6FBP, 
Pj, and the metal ion site of FBPase. Distances are in 
angstroms, and not necessarily drawn to scale. F6P and Pj 
distances were determined separately, and are shown together 
only for reference. 
Mn 
Mn 
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It has been previously noted (110) that Mn^"*" at the active site of 
rabbit liver FBPase is equidistant from the phosphorus groups of F6P and 
This result has been substantiated herein for the bovine liver 
enzyme. Interestingly, Mn^"*" is also equidistant from the C-1 and C-6 
phosphoryl groups of the product analog, aMeFBP, and from the C-2 and 
C-6 phosphoryl groups of 2,6FBP- This again indicates that the 
inhibitor, like aMeFBP, F6P, and P^, occupies the active site of FBPase. 
The Mn^"*" to phosphorus distances for F6P, P^, and AMP presented in 
this report are comparable to the values tabulated previously for rabbit 
liver FBPase (110). For each ligand, the distance calculated for the 
bovine liver FBPase is approximately 1 A shorter than that obtained with 
the rabbit liver enzyme, perhaps due to species differences. However, 
the relative positions of the three ligands is quite similar; for both 
enzymes, AMP is approximately 1 A closer to the active site Mn^"*" than 
either F6P or P^^, and the latter 2 ligands are in both instances 
equidistant from Mn^"*", as previously noted. 
In an attempt to gain an additional locus for mapping the sites 
occupied by 2,6FBP and F6P, FBPase was reacted with a nitroxide spin 
label. Bovine liver FBPase has been reported to possess one very 
reactive sulfhydryl group (33). Blocking this group with chemical 
modifiers relieves substrate inhibition, but does not otherwise affect 
the enzyme activity. Spin-labelled FBPase, however, had little (<20%) 
effect on the spin-lattice relaxation rates of the ^^P nuclei of either 
F6P or 2,6FBP. Calculations indicate that both these compounds are at 
least 9.1 A removed from the active sulfhydryl site. 
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AMP inhibition of bovine liver FBPase has been well-characterized 
through initial-rate kinetic studies of the forward (57) and reverse (54) 
reactions, as well as progress-curve analysis of the forward reaction 
(54). In addition, binding of AMP to the bovine liver FBPase allosteric 
site has been investigated in detail (57,64). The enzyme is reported to 
bind 2 (57) or 4 (64) moles of AMP per mole of tetramer. Hill, Scat-
chard, and double reciprocal plots of the binding data display complex 
curvature and have been analyzed by assuming mixed coopérâtivity (64). 
Several lines of evidence indicate synergism between AMP and 2,6FBP 
inhibition of FBPase, and this, in turn, suggests an interaction of the 
binding sites of the two inhibitors. As previously mentioned, 2,6FBP 
changes the substrate saturation curve of FBPase from hyperbolic to 
sigmoidal, and this effect is potentiated by AMP (66). In addition, 
2,6FBP protects the AMP allosteric site from inactivation by acetylation, 
and AMP and 2,6FBP induce similar ultraviolet difference spectra in the 
presence of enzyme (3). 2,6FBP is also reported to enhance the binding 
of AMP to FBPase (68); however, AMP is reported not to have an effect on 
2,6FBP binding to FBPase (69). 
Several experiments were performed to gain further insight into the 
interaction of AMP with FBPase, especially with regard to the apparent 
synergism with 2,6FBP. By measuring the temperature dependence of NMR 
line broadening of the H(2) and H(8) resonances of AMP, it was 
determined that the nucleotide is in fast exchange with FBPase. These 
results are supported by the T^p/Tzp for the ^^P nucleus of AMP 
illustrated in Table III. By graphing the line broadening as a function 
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of temperature in an Arrhenius-type plot, it was possible to obtain 
estimates of for AMP interacting with FBPase. In addition, the lower 
limit of k^^gg at 20°C was estimated from the line broadening. 
A plot of the change in the line width of H{2) and H(8) resonances 
of AMP as FBPase is titrated with nucleotide (Fig. 8) is markedly 
nonlinear. Because control experiments indicated that the change in 
line width is indeed due to AMP binding to FBPase, we have interpreted 
the nonlinearity of the titration curve to be an expression of the 
cooperative nature of AMP binding to the enzyme. 
When 2,6FBP was added to a sample of AMP and FBPase, the AMP 
resonance sharpened markedly. This rather unexpected result could 
possibly be attributed to a competition between the two compounds. This 
explanation was given by Lanier and Navon (132) for a similar effect of 
p-toluenesulfonamide on the proton resonances of sulfonilamide in a 
solution containing carbonic anhydrase, and by Neurohr et ai. (139) for 
the effect of a-methyl D-galactopyranoside on the 8 anomer of the same 
sugar in a sample containing peanut agglutin. In light of the 
accumulated evidence indicating synergism between 2,6FBP and AMP, a 
competition between the two seemed highly unlikely. Exclusive binding 
of AMP or 2,6FBP to FBPase can be conclusively ruled out by the binding 
depicted in Figure 5 which shows that 2,6FBP actually enhances the 
binding of AMP to FBPase. These results have been substantiated by 
others (68,69). 
A second explanation for the NMR data would be a change in the 
exchange mechanism of AMP and.FBPase. This possibility was tested by 
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performing the variable-temperature experiment in the presence of 2,6FBP. 
Because the line width of H(2) and H(8) of AMP remained essentially 
unchanged throughout the experiment, the slow exchange mechanism, which 
would have resulted in line broadening, could be discounted. However, 
because the line widths were quite narrow, even at 5°C, a further 
narrowing of the line resonances with raising temperature indicative of 
fast exchange, would not have been detectable within experimental error; 
therefore, it was not possible to execute an Arrhenius-type plot as 
shown in Fig. 10 for these data. However, the data do suggest a 
perturbation of the kinetics of AMP and enzyme interaction. 
Additional information on the way 2,6FBP affects the interaction of 
AMP and FBPase was obtained by measuring the enzyme-Mn to phosphorus 
distances for each ligand in the presence and absence of the other 
inhibitor. Though AMP had no effect on the distances obtained for 
2,6FBP, the sugar brought about a significant perturbation of the 
nucleotide, resulting in a increase of the distance between enzyme-bound 
Mn^* and the phosphate group of AMP. This effect was reproducible even 
at lower (1 mM) concentrations of 2,6FBP. F6P, however, had no effect 
on the distance obtained for AMP, nor did AMP affect the F5P distance. 
Results presented in this report serve to support the concept of an 
interaction between the FBPase binding sites for 2,6FBP and AMP. First, 
2,6FBP seems to cause a change in the kinetics of AMP interaction with 
FBPase. Second, 2,6FBP lengthens the distance between enzyme-bound Mn^"*" 
and the phosphorus group of AMP. These results, and those of other 
investigators, strongly suggest that the allosteric site for AMP and the 
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binding site for 2,6FBP are in proximity on the FBPase molecule. This 
idea is further substantiated by the distance measurements presented in 
this study, which indicate that the phosphorus nuclei of both the 2,6FBP 
and AMP binding sites are within 6.5 A from the enzyme-bound Mn^"*". 
The distance between bound Mn^"*" and the C-6 phosphorus atoms of F6P 
and 2,6FBP was essentially identical for bovine liver FBPase. Likewise, 
the C-2 phosphorus of 2,6FBP and P^ gave similar Mn-P distances. Also, 
both F6P and 2,6FBP are at least 9.1 A removed from the reactive 
sulfhydryl residue of FBPase. These results strongly suggest that 
2,6FBP acts at the active site of bovine liver FBPase. 
2,6FBP and the substrate, FBP, differ somewhat in the properties 
that they induce in FBPase; for instance, the two differ in the ability 
to protect FBPase from chemical modifiers (135) or proteolysis (134). 
This seeming anomaly could be ascribed to the different spatial arrange­
ment of the phosphate groups on C-1 and C-2 in FBP or 2,6E3P, respec­
tively; other studies have indicated that the substrate of FBPase is the 
a-anomer of FBP (48), whereas 2,6FBP occurs as the 8-anomer (117). 
Alternatively, 2,6FBP may act at both the active site and some distant 
allosteric site; however, this seems unlikely in light of the recent 
results of Kitajima and Uyeda (69), which do not indicate multiple 
binding of the inhibitor. Therefore, the most likely action of the 
inhibitor is a competition with the substrate for the active site of 
FBPase. 
117 
CONCLUSIONS 
and nuclear magnetic resonance were used to investigate the 
interaction of AMP and 2,6FBP with bovine liver FBPase. Mn^+ bound to 
FBPase was used as a paramagnetic probe to map the active and AMP 
allosteric sites of FBPase. Distances between enzyme-bound Mn^""" and the 
phosphorus atoms at the C-6 positions of F6P and aMeFBP were identical, 
and the enzyme-Mn to phosphorus distance determined for the C-6 
phosphorus atom of 2,6FBP was very similar to these values. Likewise, 
the enzyme-Mn to phosphorus distances for P^, the C-1 phosphorus atom of 
aMeFBP, and the C-2 phosphorus atom of 2,6FBP agreed within 0.5 Â. The 
distance between enzyme-bound Mn^"*" and the phosphorus atom of AMP was 
significantly shorter than the distances obtained for any of the 
aforementioned ligands, but the presence of 2,6FBP caused the enzyme-Mn 
to phosphorus distance for AMP to lengthen markedly. NMR line 
broadening of AMP protons was studied at various temperatures. The 
dissociation rate constant was found to be greater than 20 sec~^. The 
presence of 2,6FBP caused the proton resonances to narrow markedly, 
indicating that 2,6FBP perturbs the exchange between AMP and FBPase. 
Binding experiments indicated that 2,6FBP changes the AMP binding curve 
from sigmoidal to hyperbolic and has a positive effect on AMP binding to 
FBPase without affecting the total amount of AMP bound. It was 
concluded that 2,6FBP strongly affects the interaction of AMP with 
FBPase and that the sugar most likely acts at the active site of the 
enzyme. 
118 
GENERAL SUMMARY 
This dissertation describes studies undertaken in order to clarify 
the nature of the interaction of 2,6FBP and AMP with bovine liver 
FBPase. Of special interest were the nature of the enzyme site occupied 
by 2,6FBP and the mechanism of the synergism of inhibition exhibited in 
the presence of both AMP and 2,6FBP. 
In Part I, kinetic studies of the inhibition of the reverse FBPase 
reaction showed classical competitive inhibition for both F6P and P^ by 
2,6FBP, indicative of an active site mode of action for the inhibitor. 
An allosteric site mode of action might also explain the results 
obtained in Part I; however, the results clearly showed that the 
inhibitor acts only at one site on the enzyme, and not at both an 
allosteric and the active site. 
To gain further insight into the site of action of 2,6FBP, the 
distance between Mn^"*" bound at the active site of FBPase and the 
phosphorus groups of several FBPase ligands was determined. The 
distances obtained for F6P, P^ and aMeFBP were very similar to the 
analogous values given by 2,6FBP. Because F6P, P^, and aMeFBP all 
interact with the active site of FBPase, the results present circum­
stantial evidence that 2,6FBP also binds to the active site of FBPase. 
More conclusive evidence would have been gained if another locus from 
which to perform the distance measurements was available; however, the 
spin label which was introduced proved to be too far removed from either 
2,6FBP or F6P to provide significant relaxation for the ligands. 
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Nonetheless, this observation also indicates that F6P and 2,6FBP occupy 
similar, probably identical, sites in proximity to the enzyme-bound 
Mn^"''. Furthermore, titration of F6P-Mn-enzyme with 2,6FBP caused a 
narrowing of the phosphorus resonance of F6P, indicating competition 
between the two ligands, and therefore an active site mode of action for 
2,6FBP. 
The interaction of AMP with FBPase was investigated by monitoring 
the NMR line broadening of AMP protons at various temperatures. This 
allowed the calculation of a lower limit for the dissociation rate 
constant, as well as the energy of activation for the interaction of AMP 
with FBPase-
The distance between the phosphorus group of AMP and Mn^"*" bound at 
the active site of FBPase was obtained, and found to be significantly 
shorter than the Mn^'^'-phosphorus distances for F6P, P^, oMeFBP, and 
2,6FBP. The difference is not unexpected, because AMP is known to 
interact with an allosteric site on FBPase, whereas the other ligands 
appear to bind only at the active site of the enzyme. 
Interestingly, the phosphorus group of AMP was found to move away 
from the enzyme-bound Mn^^ when 2,6FBP was present. This suggests that 
2,6FBP causes a conformational change in the enzyme which displaces the 
phosphorus group of AMP relative to the active site Mn^"*". Additional 
evidence that 2,6FBP changes the interaction of AMP with FBPase was 
gained from binding studies, which showed that 2,6FBP enhances the 
binding of AMP to FBPase. Apparently, 2,6FBP induces a conformational 
change in the enzyme about the AMP allosteric site in a fashion which 
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results in tighter binding of AMP to FBPase. 
In conclusion, kinetic studies of the inhibition of the reverse 
reaction of raPase by 2,6FBP indicated that the inhibitor interacts only 
with one class of sites on the enzyme, and also provided inhibition 
constants with respect to the substrates, F6P and P^. The Mn-phosphorus 
distances for a number of FBPase ligands were determined by using 
^^P NMR. Because of the similarity between the values obtained for 
2,6FBP and a number of active site ligands, it was concluded that 2,6FBP 
also acts at the active site of FBPase. This conclusion is substan­
tiated by ^^P NMR studies which monitored a competition between 2,6FBP 
and F6P. Lastly, the interaction of AMP with FBPase was monitored by 
using NMR and binding studies. Proton NMR studies gave kinetic and 
thermodynamic information about the interaction of AMP with FBPase. 
^^P NMR studies allowed the calculation of the distance between 
enzyme-bound Mn^"*" and the phosphorus group of AMP. The distance 
lengthened markedly in the presence of 2,6FBP, indicative of an enzyme 
conformational change. In addition, binding studies showed that the 
interaction of AMP with FBPase is enhanced by the presence of 2,6FBP. 
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